USRE41762E1 - Nanostructured separation and analysis devices for biological membranes - Google Patents

Nanostructured separation and analysis devices for biological membranes Download PDF

Info

Publication number
USRE41762E1
USRE41762E1 US12/215,893 US21589308A USRE41762E US RE41762 E1 USRE41762 E1 US RE41762E1 US 21589308 A US21589308 A US 21589308A US RE41762 E USRE41762 E US RE41762E
Authority
US
United States
Prior art keywords
substrate
separation
nanostructured
bilayer
protrusions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime, expires
Application number
US12/215,893
Inventor
Gabriel P. Lopez
Steven R. J. Brueck
Linnea K. Ista
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNM Rainforest Innovations
Original Assignee
STC UNM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/073,935 external-priority patent/US6685841B2/en
Application filed by STC UNM filed Critical STC UNM
Priority to US12/215,893 priority Critical patent/USRE41762E1/en
Application granted granted Critical
Publication of USRE41762E1 publication Critical patent/USRE41762E1/en
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44756Apparatus specially adapted therefor
    • G01N27/44773Multi-stage electrophoresis, e.g. two-dimensional electrophoresis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/70Nanostructure
    • Y10S977/701Integrated with dissimilar structures on a common substrate
    • Y10S977/715On an organic substrate
    • Y10S977/717Lipid substrate
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/84Manufacture, treatment, or detection of nanostructure
    • Y10S977/842Manufacture, treatment, or detection of nanostructure for carbon nanotubes or fullerenes
    • Y10S977/845Purification or separation of fullerenes or nanotubes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Definitions

  • the reissue applications include co- pending U.S. patent application Ser. Nos. 12 / 215 , 893 ( the present application ) , 12 / 217 , 113 , and 12 / 217 , 114 all of which are Divisional Reissue Applications, filed as divisionals of U.S. patent application Ser. No. 11 / 825 , 298 , entitled “Nanostructured Separation and Analysis Devices for Biological Membranes,” filed on Jul. 5 , 2007 , as a Reissue of U.S. Pat. No.
  • the present invention relates to the fabrication of nanostructured matrices for use in supporting lipid bilayers for the separation and analysis of membrane-associated molecules.
  • Gradient PAGE techniques utilize one-dimensional filtration by manipulating pore-size though control of cross-linker, monomer, and solvent concentrations. Such separation matrices are recognized as having the potential to maintain excellent resolution and dynamic range. However, their utility is greatly hampered by the need for cumbersome gel preparation protocols and lack of reproducibility.
  • biomolecules The analysis and characterization of biomolecules is further limited by the difficulty in separating membrane-associated molecules. Typically, detergents are used to remove transmembrane molecules, but even mild detergents may denature such molecules, rendering them inactive and/or disrupting necessary functional interactions with other membrane components including other proteins or lipid components. Additionally, the study of biomolecules is limited by the difficulty in fabricating a cellular environment that allows for the interaction of molecules. Such interactions may be useful in studying molecular transport and communication across cell membranes.
  • lipid bilayer membranes have been incorporated into microstructured devices by lithographically-derived features to partition the supported membrane into separate regions to pattern the distribution of the lipid bilayer over the surface or as a coating for microchannels. See, Cremer, P.
  • lipid bilayers have been supported on nanostructured arrays to produce Brownian ratchets utilized in the electrophoresis of fluorescent phospholipids. See, van Oudenaarden, A., and Boxer, S. G., Brownian ratchets: Molecular separations in lipid bilayers supported on patterned arrays, Science, 285: 1046-1048 (1999), the entire contents and disclosures of which are hereby incorporated by reference.
  • hybrid lipid bilayers in which one leaflet (define leaflet) of the supported membrane is formed by an alkane-thiol monolayer on gold, have shown promise for use in bioseparations.
  • a further object of the present invention is to enable integration of multi-dimensional multi-technique molecular separation systems into a single platform.
  • Yet another object of the present invention is to provide for customized fabrication of a nanostructured separation matrix including an array having a gradient property.
  • It is yet another object of the present invention is to provide a nanostructured matrix that may cater to different ranges of molecular separations, in terms of resolution and dynamics.
  • Another object of the present invention is to enable consistency in the composition of the nanostructures forming the separation matrix.
  • Yet another object of the present invention is to enable separation and/or identification of a molecular species.
  • a further object of the present invention is to enable calibration-free use of the separation/analysis process.
  • Yet another object of the present invention is to enable multiple use of a single separation matrix.
  • a further object of the present invention is to enable parallel production of separation matrices at relatively low cost.
  • a nanostructured device comprising a substrate including at least one nanotrough therein; and a lipid bilayer suspended on the substrate.
  • a nanostructured device comprising a substrate including at least one nanotrough therein; and at least one lipid bilayer supported in at least one of the at least one nanotroughs.
  • a separation method comprising the steps of supporting or suspending a lipid bilayer on a substrate; wherein the substrate comprises at least one nanostructure and wherein the lipid bilayer comprises at least one membrane associated biomolecule; and applying a driving force to the lipid bilayer to separate the at least one membrane associated biomolecule from the lipid bilayer and to drive the at least one membrane associated biomolecule into the at least one nanostructure.
  • FIG. 1 is a micrograph showing a 150-nm period photoresist grating written with 213 nm light;
  • FIG. 2 is a micrograph showing 30-nm photoresist lines
  • FIG. 3 is a micrograph showing a 108-nm pitch photoresist grating, written using 213 nm light, and immersion in DI water.
  • FIG. 4 is a micrograph showing a photoresist line interpolated between two lines etched 360 nm apart into a nitride film demonstrating spatial period division to exentextend the spatial frequency coverage of optical lithography.
  • FIGS. 5A and 5B are micrographs showing transfer of interferometric lithography patterns into deep structures in Si using KOH anisotropic etching, with FIG. 5A showing the original period of 360 m with about 1 micrometer deep etched grooves and FIG. 5B showing the 180 nm period, frequency-doubled structure corresponding to the lithographic result of FIG. 4 ;
  • FIG. 6 illustrates in schematic form a nanostructured gradient (chirped) separation matrix
  • FIGS. 7A and 7B show perspective and top schematic views, respectively, of a nanostructured matrix according to the present invention
  • FIGS. 8A , 8 B and 8 C show high aspect ratio nanostructures fabricated by interferometric lithography and pattern transfer with FIG. 8A showing dense 150 nm photoresist lines, FIG. 8B showing an isolated 50 nm photoresist line, and FIG. 8C showing 50 nm wide walls etched in Si;
  • FIG. 9 shows a lipid bilayer suspended on a nanostructure according to an embodiment of the present invention.
  • FIG. 10 shows a suspended bilayer on a nanostructure according to an embodiment of the present invention
  • FIG. 11 shows a suspended lipid/self-assembled monolayer hybrid bilayer on a nanostructure according to an embodiment of the present invention.
  • FIG. 12 shows a bilayer supported in nanotroughs of a nanostructure according to an embodiment of the present invention.
  • nanostructure refers to a protrusion or void having a diameter in at least one direction of 1 to 500 nm.
  • the term “diameter” refers to the distance across a nanostructure through the middle and perpendicular to the axis of the nanostructure, parallel to the plane of the substrate (upon which the nanostructure is located).
  • the tern “axis” refers to a line running along the middle of a nanostructure in the direction the nanostructure's longest dimension parallel to the surface of the substrate on which the nanostructure is located.
  • protrusion refers to a structure that protrudes from the surface of a substrate or that protrudes from a portion of a substrate that has been etched.
  • the protrusions of the present invention may be any convenient size or shape.
  • the cross-section of a protrusion may be circular, square, rectangular, oval, elliptical, etc.
  • channels refers to a gap between any two protrusions.
  • the channels of the present invention may be any convenient size or shape.
  • array refers to an arrangement of nanostructures.
  • the term “gradient” refers to an array where channels, protrusions or other features at one end of the array are larger than those at an opposite end of the array.
  • continuous gradient refers to a gradient where successive rows of channels, protrusions or other features decrease in size substantially continuously from one end of the gradient to the other end of the gradient.
  • noncontinuous gradient refers to a gradient that includes regions of the gradient having successive rows of channels, protrusions or other features that are substantially the same size.
  • matrix refers to a substrate having an array of nanostructures present on or in at least a portion of the substrate.
  • a matrix of the present invention preferably has at least one gradient on or in the substrate formed by the nanostructures.
  • Examples of a matrix of the present invention include one or more arrays located on a chip, such as a semiconductor chip, biochip, etc. Methods for making biochips which may be readily adapted for use in making biochips of the present invention are described in U.S. Pat. No. 6,174,683, the entire contents and disclosure of which is hereby incorporated by reference.
  • the term “interferometric lithography” refers to a process of lithography that involves interference patterns of two (or more) mutually coherent light waves. The angles between the light propagation vectors of the waves are sufficiently large to produce an interference pattern that has a high spatial frequency. The resulting interference pattern may have nanoscale dimensions. Examples of interferometric lithography techniques that may be used in the present invention are described in Chen X L, Brueck S R J, “Imaging interferometric lithography: approaching the limits of optics” in Optics Letters, 24, pp.
  • biomolecules refers to biologically derived molecules such as peptides, small polypeptides, long polypeptides, proteins, antigens, antibodies, tagged proteins, oligonucleotides, nucleotides, polynucleotides, aptamers, DNA, RNA, carbohydrates, etc., and complexes thereof.
  • size exclusion separation process refers to separating particles, such as biomolecules, by size based on the ability of smaller particles to pass through smaller openings or channels than larger particles.
  • gel electrophoretic mobility separation process refers to any conventional electrophoresis separation technique such as two-dimensional polyacrylamide gel electrophoresis.
  • Polyacrylamide gel electrophoresis PAGE is used to separate biomolecules, usually proteins or DNA fragments, by the ratio of each biomolecule's mass to charge. Proteins may be separated in either their native state, or denatured by the addition of a detergent such as SDS (Sodium Dodecyl Sulfate). Further resolution may be obtained in some cases by making a gel with a gradient either in the concentration of the acrylamide or in the degree of crosslinking within the gel matrix.
  • An array of the present invention may be used in performing equivalent molecular weight separations, with either electrical currents or flow as the driving force.
  • the term “isoelectric focusing separation process” refers to the separation of charged biomolecules, such as proteins and peptides, by each biomolecule's isoelectric point.
  • a pH gradient is generally generated using a mixture of ampholytes within the separation matrix, usually polycrylamide polyacrylamide. The biomolecules in the mixture then migrate to the region where the pH is equal to a particular biomolecule's isoelectric point, at which time the charged biomolecule becomes electrically neutral.
  • This technique combined with subsequent separation by SDS-PAGE, is used in traditional two-dimensional gel electrophoresis.
  • Similar pH gradients may be generated using an array of the present invention including a two-dimensional gradient, using traditional isolectric isoelectric focusing with soluble ampholytes or by using chemical patterning techniques, or immobilization of ampholytes after electrical focusing.
  • capillary-based isoelectric focusing separation processes suitable for use with the present invention are described in Thorman, Tsai, Michaud, Mosher and Bier, Capillary Isoelectric-Focusing: Effects of Capillary, Geometry, Voltage Gradient and Addition of Linear Polymer, J. Chromatography, 398:75-86 (1987), the entire contents and disclosure of which are hereby incorporated by reference.
  • asymmetric diffusion separation process refers to a separation process in which steric constraints drive diffusion preferentially in one direction. Examples of asymmetric diffusion separation processes suitable for use with the present invention are described in Van Oudenaarden et al., Science, 285: 1046-1052 (1999), the entire contents and disclosure of which are hereby incorporated by reference.
  • the term “entropic trapping separation process” refers to separations using nanostructured devices of alternating thin and thick regions, with the thin regions being smaller than the radius of gyration of the biomolecule being separated. Under an electrical field, the molecules repeatedly change conformation, costing entropic free energy, thus limiting mobility.
  • An example of an entropic trapping separation process suitable for use with the present invention is described in Han J, Craighead H D, Separation of long DNA molecules in a microfabricated entropic trap array, Science, 288:1026-1029 (2000), the entire contents and disclosure of which is hereby incorporated by reference.
  • hydrophobic interaction chromatography separation process refers to a technique whereby molecules are partitioned between a hydrophobic matrix and a hydrophilic solvent.
  • the degree of hydrophobicity of the target molecule determines the target molecule's retention time.
  • the array of the present invention may be modified to incorporate a gradient of hydrophobicities or to create a milieu in which the hydrophobicity may be rapidly and reversibly changed, thus providing a driving force for molecular movement.
  • affinity chromatography separation process refers to a chromatography process that takes advantage of specific chemical interactions between a target molecule and a chromatographic matrix.
  • affinity chromatography employs immunoaffinity in which an antibody or series of antibodies are immobilized on a support.
  • Other affinity agents include enzymes that interact with specific targets or receptors.
  • affinity chromatography is a molecular recognition separation process such as the separation of long DNA molecules in a microfabricated entropic trap array.
  • An array of the present invention may be used for both the generation of affinity matrices and for the subsequent use of affinity matrices.
  • the term “enantiomeric resolution separation process” refers to a process to separate organic particles, such as biomolecules by chirality. Enantiomeric resolution is especially important in carbohydrate separations where differences between different glycosides are exclusively enantiomeric. Indeed, common chiral selectors are cyclodextrins used in capillary electrophoresis. Macrocyclic antibiotics and crown ethers are commonly used selectors. Selectors may be used either globally or in zones of an array of the present invention to confer yet another means of separation.
  • capillary electrophoresis separation process refers to a separation process in which separation takes place in a liquid rather than in a gel matrix. Capillary electrophoresis allows for separations to be done on smaller quantities of material and with improved resolution in comparison to conventional gel electrophoresis processes.
  • the channels in an array of the present invention may be arranged to generate a capillary type arrangement in a second direction following separations based on chemical properties (e.g., IEF, affinity, hydrophobic interaction chromatography or enantiomeric separation) or capillaries may be applied as a third dimension.
  • the phrase “comprises Si” refers to silicon and any silicon complex, compound, etc. that includes silicon, such as SiO 2 , glass, etc.
  • lipid refers to conventional lipids, phospholipids, etc.
  • lipid bilayer refers to any double layer of oriented amphipathic lipid molecules in which the hydrocarbon tails face inward to form a continous continuous nonpolar phase.
  • simple bilayer refers to a conventional lipid bilayer in which the bilayer is formed from micelles of phospholipids with or without membrane proteins.
  • hybrid bilayer refers to a bilayer that is derived from more than one source, either through mixing of micelles before formation, or post bilayer fusion. These also refer to bilayers in which one component is synthetically derived, or in which one leaflet is supported on the nanotextured surface prior to bilayer formation.
  • self-assembled monolayer hybrid bilayer refers to a hybrid bilayer in which the synthetic portion is composed of a self-assembled monolayer of silanes or ⁇ -substituted alkanethilates on gold.
  • the term “suspended” refers to bilayers present on a nanostructure and located above nanotroughs in a nanostructure.
  • An example of a suspended bilayer is shown in FIGS. 9 , 10 and 11 .
  • the term “supported” refers to bilayers located in nanotroughs of a nanostructure.
  • An example of a supported bilayer is shown in FIG. 12 .
  • nanotrough refers to a trough with a void dimension of 1-500 nm, whether uniform or not.
  • the term “leaflet” refers to one half of a fluid bilayer membrane composed of a single layer of phospholipids and any included proteins.
  • the term “filled with at least one fluid” refers to a nanostructure, preferably a nanotrough or channel, containing a fluid that is at least partially contained within said nanostructure.
  • the nanostructure does not need to be completely filled with a fluid according to this definition.
  • membrane associated biomolecule refers to any membrane associated biomolecule, such as transmembrane proteins, membrane phospholipids, lipophilic biomolecules, complexes thereof, etc.
  • the present invention provides, in part, for robust, inexpensive and reproducible methods for forming separation matrices for gradient separations based on, for example, electrophoresis and size exclusion that includes all the positive traits of gradient PAGE.
  • These matrices may be adapted for a host of variant separation strategies, including electrophoresis, detergent solubilization, native electrophoresis, isoelectric focusing, 2D-electrophoresis, hydrophobic interaction, and affinity chromatography. More specifically, the present invention provides for the use of such separation matrices as support for lipid bilayers that serve as separation platforms for membrane-associated biomolecules.
  • the methods of fabrication discussed herein may also be adapted to existing microfabrication and integration facilities.
  • the present invention provides for separation of molecular species across a nanostructured matrix, a method of fabricating nanostructures comprising the matrix and the use of such a matrix for separation and/or analysis of molecules by defining the physical size and/or chemical features of the nanostructures as a means of screening.
  • the nanostructured matrix may be used to separate biological materials, such as proteins, carbohydrates, and nucleic acids as well as nonbiological materials, such as synthetic polymers. These nanostructures may be made out of a variety of materials, including silicon, thus providing systems that may be easily chemically modified for additional flexibility.
  • lithography to generate nanostructured separation matrices has advantages over other techniques (such as traditional acrylamide gel polymerization) since it (1) creates highly ordered structures, (2) gives the possibility of creating macroscopic arrays of continually varying size or chemistry across one dimension, (3) is highly reproducible, and (4) may be easily implemented in the creation of complex, integrated separation systems that are disposable or reusable.
  • the use of lithographically defined separation matrices lends itself to the facile implementation of these matrices into multi-level, 3-dimensional separation devices in which different screening mechanisms allow enhanced separations.
  • the lithographic nanostructured surfaces may be used to support lipid bilayers or hybrid lipid bilayers for separating membrane-associated molecules and studying cellular interactions.
  • the present invention aims to (1) eliminate some of the current limitations by the fabrication of highly uniform and reproducible nanostructured separation systems prepared by nano- and microlithography, and (2) eliminate some of the current limitations by utilizing the lithographic nanostructured surfaces in conjunction with lipid bilayers to produce separation platforms for membrane-associated molecules.
  • IL interferometric lithography
  • IL interferometric lithography
  • it may be used to easily generate arrays of nanostructures (protrusions or channels) whose dimensions vary semi-continuously in the plane of surface of the material being patterned.
  • IL has advantages over other methods that might be used to construct nanopatterned fluidic structures (e.g., electron beam lithography, X-ray lithography, or local probe lithography) due to the low cost of implementation and the parallel nature of the lithographic technique.
  • Combining IL with conventional lithography allows for the formation of device structures in individual areas and the addition of aperiodic features such as electronic and fluidic connections.
  • Imaging interferometric lithography extends optics to fundamental, deep-subwavelength scales.
  • FIG. 1 shows an example of a large-area, 150 nm period, photoresist grating. It is important to realize that this limit is on the period, not on the feature dimensions. Nonlinearities in the exposure/develop processes and in subsequent processing may reduce the feature to dimensions well below ⁇ /4.
  • An example in FIG. 1 An example in FIG.
  • FIG. 2 shows 30-nm developed resist lines on a 360-nm pitch written at a wavelength of 364 nm.
  • the ultimate limit in linewidth is set by material properties and by uniformity of the processing; linewidths as small as 10 nm are routinely achieved.
  • the use of immersion techniques may further reduce the period by a factor of the refractive index, approximately a factor of 1.5, to a period of ⁇ 75 nm. Initial results reproduced the 150 nm pitch of FIG. 1 at a lower angle of incidence.
  • FIG. 3 shows an initial example of immersion interferometric lithography where the grating period has been reduced to 108 nm with exposure by 213 nm light using immersion in deionized water.
  • Nonlinear processes may be used to further reduce the period.
  • FIG. 4 shows an example of a photoresist line interpolated between two parallel lines that have already been transferred into a nitride layer.
  • FIG. 5B shows the result of transferring both of these patterns into Si using a KOH etch process.
  • the final period is ⁇ half of the initial IL period. Extending the calculation above with this spatial period division gives a period of ⁇ 37 nm and a dense linewidth of ⁇ 17 nm ( ⁇ /12).
  • IL may be extended deep into the nanometer regime (either to feature sizes of ⁇ 10 nm or nearest-neighbor distances (aperture sizes) of ⁇ 10 nm, but not both simultaneously).
  • a continuously varying channel spacing between nanostructures is desired for many of the bio-separation applications such as various nanofluidic configurations discussed herein.
  • One approach to a graded structure is to macroscopically vary the intensity across the plane of exposure while keeping the other interference conditions, such as the angles between the light propagation vectors and the polarization, unchanged.
  • One such variation of intensity would be a smooth gradient in intensity of one of the two interfering light waves. This results in interference fringes with uniform spacing but different intensities. The difference in intensity of the fringes leads to differences in exposure of the photoresist used. Because the fringe spacing is not changed, the pitch is uniform. The interference pattern would have even better contrast if both light waves had the same gradient in intensities.
  • this technique when used with a negative photoresist, leaves wider features in the areas corresponding to fringes with weaker intensity and narrower features in the areas corresponding to fringes with stronger intensity.
  • An alternative approach may produce features with a gradient in width and pitch. This may be easily achieved with IL by using a cylindrical lens in one of the beams, while keeping the other beam as a plane wave. In this case the plane of exposure becomes a chord for a number of circular wavefronts. Because the wavefronts have different radii of curvature (spacing of an optical wavelength), the spacing between the interference fringes, as well as the width of the interference fringes, vary along the length of the plane containing the interference fringes on the surface of the photoresist coating the substrate. Similarly, curved surfaces (sections of Newton's rings) may be formed by interfering a plane wave and a spherical wave or two spherical waves of differing radii of curvature.
  • One such system may have differing aperture sizes that may be produced by separate exposures with different intensities, at different pitches through shadow masks, or by using multiple exposure techniques to eliminate rows and/or columns of pillars in certain areas of a previously exposed uniform nano-structured surface.
  • Variations in size may also be produced chemically. For example, increasing the oxidation of silicon in certain areas of a chip may result in a swelling of the features, reducing the width of some channels while conserving the pitch of the features. Similarly, macroscopic areas may be selectively functionalized with monolayers, reducing the width of channels in that area.
  • Silicon carbide is suitable for sublimation growth, allowing one to control the width of the modified channels in a certain area.
  • silicon carbide is only one example of surface modifications that may be performed.
  • FIGS. 5A and 5B were achieved using highly anisotropic wet chemical etching of crystalline Si in KOH, which exhibits a >400:1 etch-rate selectivity for etching the ⁇ 100> plane relative to the ⁇ 111> plane of Si.
  • the vertical sidewalk are nearly perfect ⁇ 111> Si facets.
  • These structures may be further modified by oxidation. This provides insulation between the Si and the surrounding material (allowing electrophoretic fluidic manipulation) and varies the surface interactions between the nanostructure and the surrounding materials for fluidic applications.
  • Very high aspect ratio, crystal-structure-independent etching processes have been developed to address the need for 3D structures in MEMs technology.
  • Nanostructures that exhibit a gradient in their capacity to transport biomolecular species may be created by the IL processes discussed herein. Such gradients make separation matrices feasible for highly efficient separation of molecular species.
  • Molecular species may be driven in the direction of the gradient, and thus separated based on their tendency to traverse the gradient, by a variety of driving forces, including, but not limited to, electrophoresis, externally-applied pressure, capillarity, diffusion, and osmosis.
  • IL represents a convenient method for generating nanostructured separation matrices that contain physical gradients that allow selective transport of chemical species and, thus, may be used to achieve a separation of different chemicals.
  • IL is more convenient, efficient and inexpensive because it may be used to generate the entire pattern in one, parallel step and is not a serial “writing” technique.
  • Other parallel techniques e.g., imprint lithography
  • IL rely on a primary patterning technique to generate a master that may then be used to produce replicas of nanostructured features in a parallel fashion.
  • IL is a preferred method to generate nanostructured gradients for molecular separation
  • a variety of methods could be employed to generate the nanostructured matrix gradient “artificial gels” of the present invention.
  • Gradients in the chemistry of the separation matrix may be prepared by a variety of methods as well, including those based on IL.
  • Nanostructures in which channels are on the order of the excluded size of dissolved biomolecules allow an enhanced flexibility in separation. Higher resolution may be obtained in combination with any of the following mechanisms namely, size exclusion, electrophoretic mobility, isoelectric point, asymmetric diffusion, entropic trapping, hydrophobic interaction and affinity interaction (molecular recognition), as well as others.
  • the gradient matrices produced allow efficient separation and identification of biomolecules such as native proteins and protein complexes in addition to denatured proteins and nucleic acids.
  • Nanolithography-generated systems have advantages over conventional systems in terms of (1) the virtually perfect uniformity of pore size and pore size distribution from device to device, and (2) the flexibility to precisely define the required distribution (gradient) of pore sizes and pore chemistries. This high degree of reproducibility and versatility in nanofabrication will result in the ability to construct separation devices that exhibit unprecedented degrees of flexibility (resolution, dynamic range) and reproducibility in their separation characteristics.
  • the separation gradient may be formed by a variety of means including, for example, nanolithography (e.g., IL, electron beam, local probe, nanoimprint) and pattern transfer (etching, deposition, lift-off) means.
  • nanolithography e.g., IL, electron beam, local probe, nanoimprint
  • pattern transfer etching, deposition, lift-off
  • FIG. 6 shows a schematic of a nanostructured gradient (chirped) separation matrix.
  • the separation gradient may be formed by a variety of means including nanolithography (e.g., IL, electron beam, local probe, nanoimprint) and pattern transfer (etching, deposition, lift-off) means.
  • FIG. 6 illustrates a graded array of nanostructures.
  • the aperture size between the nanostructures approaches molecular dimensions.
  • the arrows signify the direction of movement of molecular species comprising the mixture to be separated and the direction of separation.
  • the height of the nanostructures is preferably sufficiently larger (e.g., 100 nm-1 ⁇ m) than the diameter to allow for higher throughput of the separated species.
  • Multiple-exposure IL moiré patterns provide for cyclic gradients that may be used for simultaneous manufacture of multiple structures. Gradients may also be fabricated across uniform patterns by non-uniform deposition or etching using properly designed deposition and/or etching tools and techniques such as oblique incidence of etch/deposition atomic/molecular species (shadowing). Analogous techniques may be used in generation of gradients in surface modification chemistry incorporated into the array.
  • FIGS. 7A and 7B show a perspective view and a top view, respectively, of a nanostructured matrix according to the present invention.
  • Matrix 700 has a plurality of protrusions 702 .
  • a sample containing some concentration of molecules moves in the direction of arrow 704 .
  • the diameter of channel 705 between protrusion 706 and protrusion 708 is larger than the diameter of channel 709 between protrusions 710 and 712 .
  • This change provides a gradient such that larger molecules are inhibited from moving the entire length of matrix 700 once the molecules encounter channels between two protrusions that are smaller than the diameter of the molecule.
  • FIGS. 7A and 7B may be extended to formation of channels to delineate the pathway for molecule movement.
  • FIG. 13 shows a top view, respectively, of a nanostructured matrix according to the present invention.
  • Matrix 1300 has a plurality of protrusions 1302 of a first size and spacing and protrusions 1303 of a second size and spacing.
  • a sample containing some concentration of molecules moves in the direction of arrow 1304 .
  • the diameter of channel 1305 between protrusion 1306 and protrusion 1308 is larger than the diameter of channel 1309 between protrusions 1310 and 1312 . This change provides a gradient such that larger molecules are inhibited from moving the entire length of matrix 1300 once the molecules encounter channels between two protrusions that are smaller than the diameter of the molecule.
  • Matrix 1300 includes a first region of the gradient having successive rows of protrusions 1302 and channels 1305 therebetween that are substantially the same size.
  • Matrix 1300 includes a second region of the gradient having successive rows of protrusions 1303 and channels 1309 therebetween that are substantially the same size.
  • IL and anisotropic wet etching of Si allow the creation of open, parallel nanostructured channels (e.g., uncapped in the direction perpendicular to the surface) with lateral features on the order of biomolecular length scales ( ⁇ 1-10 nm) but with overall dimensions reaching the microscopic ( ⁇ 100 ⁇ m) or even macroscopic ( ⁇ 1 cm or greater) scales.
  • molecular transport mechanisms may include diffusion, electrophoresis or bulkflow.
  • the relatively large vertical scale is sufficient to allow high throughput of molecules and external pumping using either electrokinetic or electro-osmotic forces. Examples of high aspect ratio IL nanostructured samples are shown in FIGS. 8A , 8 B and 8 C.
  • Such architectures are applicable to channel and post arrays that are of interest for the separation of proteins and large DNA molecules.
  • Arrays of nanostructures may be surface-modified with chemical species that enhance the separation characteristics of the matrix. These chemical species may be distributed uniformly over the nanostructured separation matrix or may be distributed in a gradient (continuous or discrete) in the direction of separation over the matrix. These chemical species may include small organic molecules, polymers, receptors or other biomolecules.
  • IL may be used to expose patterns on photoresist on silicon or other materials (which may later be etched). Silicon and some other materials may have an oxide surface that is easily modified with silanization reagents. Synthetic strategies for modification are also available for other materials (besides oxides), including native silicon and noble metals (e.g., gold). Monomolecular layers may be created from a wide range of commercially- or synthetically-available chemical species that may enhance separation characteristics based on the type and degree of interaction of chemical species being separated with the walls of the surface-modified nanostructured separation matrix.
  • Examples of types of surface modifications include the use of hydrophilic oligomeric and polymeric species (e.g., poly-ethylene glycol (PEG)) to minimize interactions of chemical species, especially proteins, with nanostructured surfaces; use of hydrophobic molecular or oligomeric species to elicit hydrophobic interaction of chemical species (especially proteins) with nanostructured surfaces; use of mixtures of hydrophobic and hydrophilic species (polar, apolar, H-bonding, ionic) to tune interaction of different chemical species with surfaces; use of ionic molecular species and mixtures of ionic species to tune interaction of different chemical species with surfaces; use of biomolecular or organic receptors to elicit molecular recognition of small molecules, polymers, proteins, DNA, RNA, or oligonucleotides with the surface; use of oligonucleotide probes to tune interactions of DNA, RNA or nucleic-acid binding proteins with the surface; use of cyclodextrins, macrocyclic
  • separation systems of the present invention may be thought of as having discontinuous gradients. These separation systems contain areas with different aperture sizes, and may be made either by separate exposures at different intensity, at different pitches through shadow masks, or by using multiple exposure techniques to eliminate rows and/or columns of pillars. Such systems are especially useful in that they will allow recovery of separated compounds (purification).
  • the present invention allows a variety of different separation strategies (electrophoresis, iso-electric focusing, affinity chromatography, hydrophobic interaction chromatography, enantiomeric resolution) to be used on a single monolithic device, thus allowing for ease of use and compactness of instrumentation.
  • 2DGE Two-dimensional gel electrophoresis
  • proteins are first separated according to isoelectric point, followed by resolution by mass-to-charge-ratio using standard polyacrylamide electrophoresis. This process requires that two separate electrophoretic procedures be performed, each requiring manipulation of the sample.
  • a nanostructured matrix of the present invention allows for sequential analysis on a single chip, thus reducing sample loss and diffusion.
  • the wide range of chemical modifications and array architecture allowed by IL devices will also permit separation of proteins by means in addition to size and isoelectric point, either by appropriate chemical patterning and valving of the device, or by addition of a third separation and/or dilution dimension.
  • the nanostructured matrix of the present invention may be used for two-dimensional gel electrophoresis, and a number of other separation techniques may be combined with size exclusion and/or isoelectric focusing.
  • the matrix has the capability of expansion beyond two dimensions.
  • Combining two or more standard types of analysis on a single platform may enhance the analytical potential of a nanostructured matrix of the present invention.
  • separation technologies applicable to this platform are those analogous to PAGE, isoelectric focusing, hydrophobic interaction chromatography, affinity chromatography, enantiomeric resolution and capillary electrophoresis.
  • the matrix lends itself well to carrying out equivalent molecular weight separations, with either electrical currents or flow as the driving force.
  • the present invention may be useful in proteomics by enabling combinations of different types of analysis, e.g., size exclusion in one dimension with chemical differentiation in the second.
  • a third dimension, oriented perpendicular to the two dimensional array, may then be used for further separation, or for recovery and further characterization of isolated spots.
  • the present invention may also find use in protein separations for forensic and medical diagnostic tools and in the separation of bioengineered proteins. Forensic analysis and diagnostics, for example, depend heavily upon differentiation between carbohydrate moieties on blood proteins and bacterial cells. Discovery of clinically useful drugs often depends on identifying interactions with specific cellular receptors, which are usually glycoproteins. Capillary electrophoresis has been extremely useful in separations of acid carbohydrates, with derivatization of the column.
  • the present invention allows for the separation of two properties, for example glycoprotein size and carbohydrate content on a single platform, thus eliminating the need for cumbersome recovery between steps and increasing the yield of useful analyte.
  • the present invention allows sequential analysis of at least two different properties, thus increasing sensitivity of analysis, with particular interest for environmental monitoring.
  • the present invention allows for separation of a variety of sizes of nucleic acid species, and thus, may be used for separations that are currently done by standard and pulsed-field gel electrophoresis, as well as nucleic acid sequencing.
  • modification of the device by nucleic acid-binding molecules e.g., proteins, drugs
  • nucleic acid-binding molecules e.g., proteins, drugs
  • separation may be multidimensional, these devices may be attached in series with a reaction chamber (for example, a PCR thermocycler) and the resultant product directly fed into the separation platform for purification and analysis in a single device.
  • IL may be used to create nanostructures on a variety of substrates.
  • IL in combination with other standard lithographic and microfabrication methodologies, may be used to create a variety of nanostructures that may be modified in many ways to produce tools for separation of relevant biomolecules. These have advantages over contemporary molecular separation systems because they exhibit superior performance (resolution, sensitivity, dynamic range, applicability, reproducibility), may be parallel-produced at relatively low cost, and are extremely flexible in terms of chemical modifications. They have defined features that may be reproducibly made, enable flexible and complex separation, and may be used with existing bioseparation and detection strategies.
  • An additional aspect of the present invention is the use of defined lithographic nanostructures to suspend or support lipid bilayers and hybrid lipid bilayers as a separation platform for membrane-associated biomolecules.
  • This invention expands upon previous methods for (1) incorporating lipid bilayers and nanostructured surfaces for separation techniques, and (2) creating lipid bilayers in which regions of the lipid bilayers are freely suspended or supported between two aqueous reservoirs.
  • the present invention utilizes suspended or supported lipid bilayer architecture in the separation of transmembrane molecules.
  • FIG. 9 shows lipid bilayer 902 suspended on nanostructure 904 .
  • the dimensions of nanotroughs 906 are such that lipid bilayer 902 may be suspended on nanostructure 904 over the nanotrough, allowing for domains of biomolecules 908 exterior to the membrane to segregate into these troughs for separation.
  • These structures are made by spontaneous assembly of lipid bilayers from lipid micelles on a hydrophilic surface.
  • Transmembrane proteins and other biomolecules may be incorporated either during the formation of the micelles or formation of the membrane through fusion of micelles incorporating them or membrane ghosts. Certain membrane proteins are also capable of self-directed insertion into the membrane and these may be incorporated by direct insertion into the membrane.
  • FIGS. 10 , 11 and 12 show various bilayers that may be associated with a particular nanostructure according to embodiments of the present invention.
  • FIG. 10 shows a generic bilayer 1002 suspended on nanostructure 1004 over nanotroughs 1006 .
  • FIG. 11 shows a suspended lipid/self-assembled monolayer hybrid bilayer 1102 on nanostructure 1104 having nanotroughs 1106 .
  • This bilayer type of structure forms spontaneously when a monolayer containing hydrocarbon-like chains are present on the nanostructures. In this configuration, fluidity of the lower leaflets in the supported region is lost, as that leaflet is fixed. Transmembrane proteins and other membrane biomolecules are expected to move preferentially in those areas with greatest total membrane fluidity, i.e. in the troughs.
  • FIG. 12 shows bilayer 1202 supported in nanotroughs 1206 in nanostructure 1204 .
  • This sort of structure may be achieved through selective modification of the tops of the nanostructures such that they would not support bilayer formation (e.g., hydrophobic modification) and through use of micelles that are smaller than the diameter of the nanotrough.
  • nanofabricated arrays of structures that exhibit a gradient in their capacity to transport molecules.
  • Such gradient structures allow for separation matrices that eliminate the requirement for detergent solubilization, and thus denaturation, of transmembrane biomolecules prior to separation, which is the current state of the art.
  • Such gradient structures allow molecular species to be driven in the direction of the gradient, thereby separating the molecules based on their tendency to traverse the gradient.
  • Molecular species may be driven across the gradient by forces such as electrophoresis, externally-applied pressure, capillarity, diffusion, and osmosis.
  • forces such as electrophoresis, externally-applied pressure, capillarity, diffusion, and osmosis.
  • several modifications of the nanostructured support that will enhance separation within the supported or suspended bilayer are envisioned.
  • An embodiment of the present invention suspends lipid bilayer membranes over a series of small gaps, approximately 100 nm in size, and utilizes the entire supported membrane as a separation and analysis platform. The small sizes of the gaps between features allows the lipid bilayer membrane to be suspended over the gaps, which allows for preferential movement of membrane phospholipids, transmembrane proteins, and other lipophilic biomolecules, and their complexes.
  • the relative fluidity of the lower leaflet of the lipid bilayer in the suspended regions results in greater mobility of transmembrane molecules.
  • separations may be based on molecular filtering mechanisms in addition to electrophoretic mobility. Because the areas scanning the gaps may be supported on the underside by aqueous media, more room may also be available for intercellular domains.
  • biophysical studies both of interactions between extra and intercellular domains of a single protein, and/or of interactions between intercellular domains of proteins within the same membrane are provided by the present invention.
  • suspended lipid bilayer membranes offer several advantages over the current state of the art, particularly in regard to the separation and concentration of transmembrane proteins.
  • alkane-chain terminated self-assembled monolayers may be formed on the top surfaces of the nanostructured surfaces, either by silane modification of Si substrates or ⁇ -substitued ⁇ - substituted alkanethiols on, for example, gold. It is anticipated that these structures may provide even greater mobility of lipophilic biomolecules in supported and non-supported regions of the lipid bilayer membrane due to the immobility of the chemically fixed lower leaflet in the hybrid region.
  • IL may produce a variety of features, including posts and grooves, in nearly infinite combinations of types and arrangements. Such features may be arranged in a regular array, thus mimicking standard gels, with the features either shaped or arranged in an asymmetric manner, or as semidiscontinuous, or chirped, arrays that vary in their size and/or separation distance along the direction of separation. Furthermore, a combination of grooves and/or posts may be arranged to achieve configurations that allow for two-dimensional separations.
  • the present invention may be used for separation of membranes from osmotically disrupted cells (cell ghosts). This is particularly significant because no previous isolation of membrane-associated biomolecules is necessary, thus preserving the biomolecules' native conformations and complexes.
  • the nanostructured surfaces and lipid bilayer membranes may be combined in such a way to modify only the tops of the features, the lower surface of the nanostructured surface, the sides of the features, or any combination thereof.
  • lipid bilayer membranes containing different molecules, or derived from different organelles within a cell may be patterned on the nanostructured surface, thereby conferring a certain level of selectivity within the membrane itself, either due to innate properties of the molecules or the presence of interactive biomolecules within a region of the pattern.
  • the present invention may be utilized in several manners to facilitate the study of biomolecules.
  • the nanostructured surfaces supporting lipid bilayer membranes may be utilized in biophysics to study membrane components. Because, within the suspended regions, neither leaflet of the membrane may be immobilized on the surface, total membrane fluidity may be increased, thus allowing for greater mobility of embedded biomolecules and creating an experimental milieu more closely replicating that found in the cell. Furthermore, interactions between cytoplasmic and extracellular domains may be more easily studied.
  • the present device shows promise as a biosensor device. Because the structure allows for proper orientation of the intercellular domains of transmembrane proteins, natural or engineered receptor proteins may take advantage of naturally occurring transduction mechanisms to facilitate signal transduction.
  • the present invention may further be useful in purification.
  • the nanostructured lipid bilayer device may provide a unique platform on which to purify lipophilic membrane biomolecules. Because the components may be applied from membrane cell ghosts or in lipid micelles, the need for harsh and possibly denaturing detergent extraction may be unnecessary. In addition, complexes of associated proteins may be purified intact, thereby improving the study of pharmaceutical agents.
  • the present device may also be useful in the crystallization of membrane proteins to provide more pertinent information as to the structure and function of the proteins.
  • the nanostructured lipid bilayer device may be manufactured to produce a gradient of features so that the protein in question aggregates at a single band in the device, thereby accumulating at the critical concentration.
  • the present invention may allow for greater flexibility in screening potential pharmaceutical agents.
  • the nanostructured lipid bilayer device may facilitate observation of interactions between target transmembrane molecules and potential therapeutic agents within a defined membrane milieu, as well as allow for in vitro study of the resultant interactions between the drug-bound receptor and other components within the target complexes.
  • the present invention allows for unprecedented advances in the study of biomembranes and their associated molecules.
  • membrane associated biomolecules may be applied to the present device, either via cell ghosts or vesicles, without first isolating them in aqueous media using detergent solubilization means that native configurations, associations and, thus, functionality may be preserved.
  • microscale electrophoresis cells incorporated much of the characteristics of the present invention into a compact system.
  • the cell preferably has the following characteristics: (1) electrochemical current and fluid flow is restricted to occur only through the separation matrix; (2) loading and stacking functions are included; (3) monitoring of mobility and biomolecular detection is possible (e.g., through fluorescence imaging); and (4) for certain applications, separated compounds are recoverable.
  • Simple methods have been used for incorporating nanostructured silicon/silica chips into electrophoresis cells that satisfy criteria (1-3) above. For example, simple methods of rapid prototyping of elastomeric gasket materials have been used.
  • Supported phospholipid bilayers (SPBs) of egg phosphatidyl choline (Egg PC) were formed by vesicle fusion on nanostructured silicon wafers containing troughs ⁇ 180 nm in width on a 360 nm pitch. An intercalating dye was introduced, and the membranes were imaged by scanning laser microscopy. The resultant fluorescence micrographs indicated that the SPBs formed uniformly over the surface and simple FRAP measurements indicated that the bilayers were fluid and that recovery of fluorescence was preferentially in the direction parallel to the nanotroughs.
  • SPBs egg phosphatidyl choline
  • Transmembrane or membrane associated proteins may be incorporated into an SPB, from incorporation in the vesicle stage, insertion on the membrane or through incorporation of cell ghosts (i.e., intact membranes isolated from cells or organelles).
  • the architecture and/or chemistry of the underlying nanotextured support would be then used to guide the movement of membrane proteins through the supported or suspended bilayer, either by size exclusion of the trough over which the membrane is supported, or by chemical interactions with modifications on the nanostructured support.

Abstract

The present invention provides a nanostructured device comprising a substrate including nanotroughs therein; and a lipid bilayer suspended on or supported in the substrate. A separation method is also provided comprising the steps of supporting or suspending a lipid bilayer on a substrate; wherein the substrate comprises nanostructures and wherein the lipid bilayer comprises at least one membrane associated biomolecule; and applying a driving force to the lipid bilayer to separate the membrane associated biomolecule from the lipid bilayer and to drive the membrane associated biomolecule into the nanostructures.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a Continuation-in-Part of and claims priority to U.S. patent application No. 10/073,935, entitled “Nanostructured Devices for Separation and Analysis,” filed on Feb. 14, 2002, now U.S Pat. No. 6,685,841 B2 issued on Feb. 3, 2004, which claims priority to U.S. Provisional Patent Application No. 60/268,365, entitled “Nanostructured Devices for Separation and Analysis,” filed Feb. 14, 2001. This application also claims priority to U.S. Provisional Patent Application No. 60/347,002, entitled “Nanostructured Devices,” filed on Jan. 11, 2002. The entire contents and disclosures of the above applications are hereby incorporated by reference.
Notice: more than one reissue application has been filed for the reissue of U.S. Pat. No. 6,913,697 B2. The reissue applications include co-pending U.S. patent application Ser. Nos. 12/215,893 (the present application), 12/217,113, and 12/217,114 all of which are Divisional Reissue Applications, filed as divisionals of U.S. patent application Ser. No. 11/825,298, entitled “Nanostructured Separation and Analysis Devices for Biological Membranes,” filed on Jul. 5, 2007, as a Reissue of U.S. Pat. No. 6,913,697 B2 issued on Jul. 5, 2005, which was filed as application Ser. No. 10/338,654 entitled “Nanostructured Separation and Analysis Devices for Biological Membranes,” on Jan. 9, 2003, as a Continuation-in-Part of U.S. patent application Ser. No. 10/073,935, entitled “Nanostructured Devices for Separation and Analysis,” filed on Feb. 14, 2002, now U.S. Pat. No. 6,685,841 B2 issued on Feb. 3, 2004, which claims priority to U.S. Provisional Patent Application No. 60/268,365, entitled “Nanostructured Devices for Separation and Analysis,” filed on Feb. 14, 2001. This application also claims priority to U.S. Provisional Patent Application No. 60/347,002, entitled “Nanostructured Devices,” filed on Jan. 11, 2002. The entire contents and disclosures of the above applications are hereby incorporated by reference.
GOVERNMENT INTEREST STATEMENT
This invention is made with government support under grant number DAAD19-99-1-0196 awarded by the United States Army Research Office. The government may have certain rights in this invention.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the fabrication of nanostructured matrices for use in supporting lipid bilayers for the separation and analysis of membrane-associated molecules.
2. Description of the Prior Art
The demand for precise separation of molecules using small sample volumes is increasing. Currently, polyacrylamide gel electrophoresis (PAGE) remains the standard for protein separation and identification in biotechnology. However, the set of separation strategies that rely on this technique are hampered by: (1) inconvenience of preparation of the variety of gels needed for the separations, (2) inherent inconsistencies in production conditions; and therefore, irreproducibility between different batches of gels, (3) susceptibility of the polymer to degradation under high electric fields, (4) lack of reusability, (5) difficulty in incorporation of these techniques into strategies for development of multi-dimensional (multi-technique) integrated separation systems, and (6) limited resolution and dynamic range of biomolecular separations.
Gradient PAGE techniques utilize one-dimensional filtration by manipulating pore-size though control of cross-linker, monomer, and solvent concentrations. Such separation matrices are recognized as having the potential to maintain excellent resolution and dynamic range. However, their utility is greatly hampered by the need for cumbersome gel preparation protocols and lack of reproducibility.
In general, the separation of molecules across matrices or membranes has been known in the art. Such separations are typically achieved by employing barriers that allow cut-offs at a precise molecular weight or by size-exclusion. The art describes structures where molecular transport and filtration take place perpendicular to the surface of the separating material. These currently available systems, however, suffer from a number of drawbacks: (1) the matrices formed are generally composed of non-uniform structures, (2) even where a gradation in size of structures is required, they may be random or at best have to be serially and sequentially arrayed through a cumbersome process of lithography, (3) fabrications of separation devices pose problems in terms of batch-to-batch variations; and consequently, poor reproducibility of results therefrom, (4) lack of efficiency of separation, (5) loss of sample volume, and (6) biomolecules may not be amenable to separation by many of the available systems.
Thus far, the most relevant work has been the development of “Brownian ratchets” in which assymetric diffusion leads to separation of molecules based on their size (van Oudenaarden et al., Science, 285: 1046-1052, 1999, the entire contents and disclosure of which is hereby incorporated by reference). Subsequently, Chou et al. (see, Chou et al., Proc. Natl. Acad. Sci., 96, 13762-13765, 1999, the entire contents and disclosure of which is hereby incorporated by reference) attempted separation of DNA molecules using Microsystems formed by conventional photolithography. Although such prior work demonstrated that relatively simple 3-dimensional architectures could lead to effective separation, the developments have not gained ground with the biotechnological community. The primary reasons for this lack of acceptance being the difficulty of preparation of the nanofluidic systems and the associated high-cost of fabrication.
Similarly, “artificial gels” incorporating regular arrays of nanoscale pillars created through electron beam and/or imprint lithography have been described, for instance, in U.S. Pat. No. 6,110,339 to Yager, et al. and by Turner, et al. (J. Vac. Sci. Technol. B., 16 3835-3840, 1998, the entire contents and disclosure of which is hereby incorporated by reference). Such nanolithographically-defined structures utilize regular arrays of uniform-sized nanostructures throughout the separation matrix. Although these nanolithographic structures are useful in separation, the systems suffer from drawbacks: (1) resolution limitations, (2) flexibility limitations, and (3) difficulty in integrating the system with other, more complex, separation devices. Thus, the need for an efficient, highly-resolving, flexible, cost-efficient, and reproducible molecular-separation matrix, is largely unmet.
The analysis and characterization of biomolecules is further limited by the difficulty in separating membrane-associated molecules. Typically, detergents are used to remove transmembrane molecules, but even mild detergents may denature such molecules, rendering them inactive and/or disrupting necessary functional interactions with other membrane components including other proteins or lipid components. Additionally, the study of biomolecules is limited by the difficulty in fabricating a cellular environment that allows for the interaction of molecules. Such interactions may be useful in studying molecular transport and communication across cell membranes.
Thus far, the most relevant work in this area is the use of synthetic lipid bilayer membranes as separation platforms for biomolecules. Because of their planar structure, such membranes are more amenable to laboratory use. The separation technology is achieved by integrating planar lipid bilayers with varied surfaces to allow for separation of molecules. For instance, synthetic membranes supported on a glass or silica surface allow for the electrophoretic separation of labeled phospholipids and membrane proteins. See, Groves, J. T. and Boxer, S. G., Electric-field-induced concentration gradients in planar supported bilayers, Biophysical Journal, 69: 1972-1975 (1995), and Groves, J. T., Wulfing, C., and Boxer, S. G., Electrical manipulation of glycan phosphatidyl inositol tethered proteins in planar supported bilayers, Biophysical Journal, 71: 2716-2723 (1996), the entire contents and disclosures of which are hereby incorporated by reference. Additionally, lipid bilayer membranes have been incorporated into microstructured devices by lithographically-derived features to partition the supported membrane into separate regions to pattern the distribution of the lipid bilayer over the surface or as a coating for microchannels. See, Cremer, P. S., and Yang, T., Creating spatially addressed arrays of planar supported fluid phospholipid membranes, Proceedings of the National Academy of Sciences, U.S.A., 121: 8130-8131; Nissen, J., Jacobs, K., and Radler, J. O., Interface dynamics of lipid membrane spreading on solid surfaces, Physical Review Letters, 86: 1904-1907 (2001); and Yang, T. L., Jung, S. Y., Mao, H. B., and Cremer, P. S., Fabrication of phospholipid bilayer-coated microchannels for on-chip immunoassays, Analytical Chemistry, 73: 165-169 (2001), the entire contents and disclosures of which are hereby incorporated by reference. Furthermore, lipid bilayers have been supported on nanostructured arrays to produce Brownian ratchets utilized in the electrophoresis of fluorescent phospholipids. See, van Oudenaarden, A., and Boxer, S. G., Brownian ratchets: Molecular separations in lipid bilayers supported on patterned arrays, Science, 285: 1046-1048 (1999), the entire contents and disclosures of which are hereby incorporated by reference. Finally, hybrid lipid bilayers, in which one leaflet (define leaflet) of the supported membrane is formed by an alkane-thiol monolayer on gold, have shown promise for use in bioseparations. See, Plant, A., Supported hybrid bilayer membranes as rugged cell membrane mimics, Langmuir, 15: 5128-5135 (1999), and Hui, et al., U.S. Pat. No. 5,919,576, the entire contents and disclosures of which are hereby incorporated by reference. However, in these techniques, the close proximity or constraint of the lower leaflet to the supporting surface reduces their usefulness in analyzing transmembrane proteins or interactions between cytoplasmic and extracellular components of the membrane.
Also relevant to the technology of the present invention are previous methods for creating suspended lipid bilayers in which regions of the lipid bilayers are freely suspended between two aqueous reservoirs. Such hybrid bilayers are formed so one leaflet of the suspended region of the bilayer is replaced with a methyl terminated self-assembled monolayer, allowing for suspension of free bilayers over gaps as large as 100 um. See, Ogier, S. D., Bushby, R. J., Cheng, Y., Evans, S. D., Evand, S. W., Jenkins, T. A., Knowles, P. F., and Miles, R. E., Langmuir, 16: 5696-5701 (2000), the entire contents and disclosures of which are hereby incorporated by reference. Although these types of suspended bilayers have been used for studying membrane permeability and transmembrane protein function, the use of such suspended lipid bilayers in the separation of transmembrane proteins has not been examined. Thus, the need for technology that utilizes supported and suspended lipid bilayer membranes that allow for (1) separation of membrane-spanning complexes, and (2) cellular interaction is largely unmet.
SUMMARY OF THE INVENTION
It is therefore an object of the present invention to provide an efficient nanostructured matrix for separation and analysis of molecules.
It is a further object of the present invention to provide a matrix that enables gradient or non-uniform transport of molecules across a plane parallel to the surface of the matrix.
A further object of the present invention is to enable integration of multi-dimensional multi-technique molecular separation systems into a single platform.
Yet another object of the present invention is to provide for customized fabrication of a nanostructured separation matrix including an array having a gradient property.
It is yet another object of the present invention is to provide a nanostructured matrix that may cater to different ranges of molecular separations, in terms of resolution and dynamics.
Another object of the present invention is to enable consistency in the composition of the nanostructures forming the separation matrix.
Yet another object of the present invention is to enable separation and/or identification of a molecular species.
A further object of the present invention is to enable calibration-free use of the separation/analysis process.
Yet another object of the present invention is to enable multiple use of a single separation matrix.
A further object of the present invention is to enable parallel production of separation matrices at relatively low cost.
In all of the above embodiments, it is an object to provide enhanced reproducibility and resolution in the separation of molecules.
According to a first broad aspect of the present invention, there is provided a nanostructured device comprising a substrate including at least one nanotrough therein; and a lipid bilayer suspended on the substrate.
According to second broad aspect of the invention, there is provided a nanostructured device comprising a substrate including at least one nanotrough therein; and at least one lipid bilayer supported in at least one of the at least one nanotroughs.
According to a third broad aspect of the invention, there is provided a separation method comprising the steps of supporting or suspending a lipid bilayer on a substrate; wherein the substrate comprises at least one nanostructure and wherein the lipid bilayer comprises at least one membrane associated biomolecule; and applying a driving force to the lipid bilayer to separate the at least one membrane associated biomolecule from the lipid bilayer and to drive the at least one membrane associated biomolecule into the at least one nanostructure.
Other objects and features of the present invention will be apparent from the following detailed description of the preferred embodiment.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention will be described in conjunction with the accompanying drawings, in which:
FIG. 1 is a micrograph showing a 150-nm period photoresist grating written with 213 nm light;
FIG. 2 is a micrograph showing 30-nm photoresist lines;
FIG. 3 is a micrograph showing a 108-nm pitch photoresist grating, written using 213 nm light, and immersion in DI water.
FIG. 4 is a micrograph showing a photoresist line interpolated between two lines etched 360 nm apart into a nitride film demonstrating spatial period division to exentextend the spatial frequency coverage of optical lithography.
FIGS. 5A and 5B are micrographs showing transfer of interferometric lithography patterns into deep structures in Si using KOH anisotropic etching, with FIG. 5A showing the original period of 360 m with about 1 micrometer deep etched grooves and FIG. 5B showing the 180 nm period, frequency-doubled structure corresponding to the lithographic result of FIG. 4;
FIG. 6 illustrates in schematic form a nanostructured gradient (chirped) separation matrix;
FIGS. 7A and 7B show perspective and top schematic views, respectively, of a nanostructured matrix according to the present invention;
FIGS. 8A, 8B and 8C show high aspect ratio nanostructures fabricated by interferometric lithography and pattern transfer with FIG. 8A showing dense 150 nm photoresist lines, FIG. 8B showing an isolated 50 nm photoresist line, and FIG. 8C showing 50 nm wide walls etched in Si;
FIG. 9 shows a lipid bilayer suspended on a nanostructure according to an embodiment of the present invention;
FIG. 10 shows a suspended bilayer on a nanostructure according to an embodiment of the present invention;
FIG. 11 shows a suspended lipid/self-assembled monolayer hybrid bilayer on a nanostructure according to an embodiment of the present invention; and
FIG. 12 shows a bilayer supported in nanotroughs of a nanostructure according to an embodiment of the present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
It is advantageous to define several terms before describing the invention. It should be appreciated that the following definitions are used throughout this application.
Definitions
Where the definition of terms departs from the commonly used meaning of the term, applicant intends to utilize the definitions provided below, unless specifically indicated.
For the purposes of the present invention, the term “nanostructure” refers to a protrusion or void having a diameter in at least one direction of 1 to 500 nm.
For the purposes of the present invention, the term “diameter” refers to the distance across a nanostructure through the middle and perpendicular to the axis of the nanostructure, parallel to the plane of the substrate (upon which the nanostructure is located).
For the purposes of the present invention, the tern “axis” refers to a line running along the middle of a nanostructure in the direction the nanostructure's longest dimension parallel to the surface of the substrate on which the nanostructure is located.
For the purposes of the present invention, the term “protrusion” refers to a structure that protrudes from the surface of a substrate or that protrudes from a portion of a substrate that has been etched. The protrusions of the present invention may be any convenient size or shape. The cross-section of a protrusion may be circular, square, rectangular, oval, elliptical, etc.
For the purposes of the present invention, the term “channel” refers to a gap between any two protrusions. The channels of the present invention may be any convenient size or shape.
For the purposes of the present invention, the term “array” refers to an arrangement of nanostructures.
For the purposes of the present invention, the term “gradient” refers to an array where channels, protrusions or other features at one end of the array are larger than those at an opposite end of the array.
For the purposes of the present invention, the term “continuous gradient” refers to a gradient where successive rows of channels, protrusions or other features decrease in size substantially continuously from one end of the gradient to the other end of the gradient.
For the purposes of the present invention, the term “noncontinuous gradient” refers to a gradient that includes regions of the gradient having successive rows of channels, protrusions or other features that are substantially the same size.
For the purposes of the present invention, the term “matrix” refers to a substrate having an array of nanostructures present on or in at least a portion of the substrate. A matrix of the present invention preferably has at least one gradient on or in the substrate formed by the nanostructures. Examples of a matrix of the present invention include one or more arrays located on a chip, such as a semiconductor chip, biochip, etc. Methods for making biochips which may be readily adapted for use in making biochips of the present invention are described in U.S. Pat. No. 6,174,683, the entire contents and disclosure of which is hereby incorporated by reference.
For the purposes of the present invention, the term “interferometric lithography” (IL) refers to a process of lithography that involves interference patterns of two (or more) mutually coherent light waves. The angles between the light propagation vectors of the waves are sufficiently large to produce an interference pattern that has a high spatial frequency. The resulting interference pattern may have nanoscale dimensions. Examples of interferometric lithography techniques that may be used in the present invention are described in Chen X L, Brueck S R J, “Imaging interferometric lithography: approaching the limits of optics” in Optics Letters, 24, pp. 124-126 (1999), in “Imaging interferometric lithography: A wavelength division multiplex approach to extending optical lithography, Chen X L, Brueck S R J, Journal of Vacuum Science and Technology B, vol. 16, pp. 3392-3397 (1998), in U.S. Pat. No. 5,759,744 to Brueck et al., in U.S. Pat. No. 6,233,044 to Brueck et al., and U.S. Pat. No. 6,042,998 to Brueck et al., the entire contents and disclosures of which are hereby incorporated by reference.
For the purposes of the present invention, the term “biomolecules” refers to biologically derived molecules such as peptides, small polypeptides, long polypeptides, proteins, antigens, antibodies, tagged proteins, oligonucleotides, nucleotides, polynucleotides, aptamers, DNA, RNA, carbohydrates, etc., and complexes thereof.
For the purposes of the present invention, the term “size exclusion separation process” refers to separating particles, such as biomolecules, by size based on the ability of smaller particles to pass through smaller openings or channels than larger particles.
For the purposes of the present invention, the term “gel electrophoretic mobility separation process” refers to any conventional electrophoresis separation technique such as two-dimensional polyacrylamide gel electrophoresis. Polyacrylamide gel electrophoresis (PAGE) is used to separate biomolecules, usually proteins or DNA fragments, by the ratio of each biomolecule's mass to charge. Proteins may be separated in either their native state, or denatured by the addition of a detergent such as SDS (Sodium Dodecyl Sulfate). Further resolution may be obtained in some cases by making a gel with a gradient either in the concentration of the acrylamide or in the degree of crosslinking within the gel matrix. An array of the present invention may be used in performing equivalent molecular weight separations, with either electrical currents or flow as the driving force.
For the purposes of the present invention, the term “isoelectric focusing separation process” refers to the separation of charged biomolecules, such as proteins and peptides, by each biomolecule's isoelectric point. A pH gradient is generally generated using a mixture of ampholytes within the separation matrix, usually polycrylamide polyacrylamide. The biomolecules in the mixture then migrate to the region where the pH is equal to a particular biomolecule's isoelectric point, at which time the charged biomolecule becomes electrically neutral. This technique, combined with subsequent separation by SDS-PAGE, is used in traditional two-dimensional gel electrophoresis. Similar pH gradients may be generated using an array of the present invention including a two-dimensional gradient, using traditional isolectric isoelectric focusing with soluble ampholytes or by using chemical patterning techniques, or immobilization of ampholytes after electrical focusing. Examples of capillary-based isoelectric focusing separation processes suitable for use with the present invention are described in Thorman, Tsai, Michaud, Mosher and Bier, Capillary Isoelectric-Focusing: Effects of Capillary, Geometry, Voltage Gradient and Addition of Linear Polymer, J. Chromatography, 398:75-86 (1987), the entire contents and disclosure of which are hereby incorporated by reference.
For the purposes of the present invention, the term “asymmetric diffusion separation process” refers to a separation process in which steric constraints drive diffusion preferentially in one direction. Examples of asymmetric diffusion separation processes suitable for use with the present invention are described in Van Oudenaarden et al., Science, 285: 1046-1052 (1999), the entire contents and disclosure of which are hereby incorporated by reference.
For the purposes of the present invention, the term “entropic trapping separation process” refers to separations using nanostructured devices of alternating thin and thick regions, with the thin regions being smaller than the radius of gyration of the biomolecule being separated. Under an electrical field, the molecules repeatedly change conformation, costing entropic free energy, thus limiting mobility. An example of an entropic trapping separation process suitable for use with the present invention is described in Han J, Craighead H D, Separation of long DNA molecules in a microfabricated entropic trap array, Science, 288:1026-1029 (2000), the entire contents and disclosure of which is hereby incorporated by reference.
For the purposes of the present invention, the term “hydrophobic interaction chromatography separation process” refers to a technique whereby molecules are partitioned between a hydrophobic matrix and a hydrophilic solvent. The degree of hydrophobicity of the target molecule determines the target molecule's retention time. The array of the present invention may be modified to incorporate a gradient of hydrophobicities or to create a milieu in which the hydrophobicity may be rapidly and reversibly changed, thus providing a driving force for molecular movement.
For the purposes of the present invention, the term “affinity chromatography separation process” refers to a chromatography process that takes advantage of specific chemical interactions between a target molecule and a chromatographic matrix. One of the most widely used forms of affinity chromatography employs immunoaffinity in which an antibody or series of antibodies are immobilized on a support. Other affinity agents include enzymes that interact with specific targets or receptors. Another example of affinity chromatography is a molecular recognition separation process such as the separation of long DNA molecules in a microfabricated entropic trap array. An array of the present invention may be used for both the generation of affinity matrices and for the subsequent use of affinity matrices.
For the purposes of the present invention, the term “enantiomeric resolution separation process” refers to a process to separate organic particles, such as biomolecules by chirality. Enantiomeric resolution is especially important in carbohydrate separations where differences between different glycosides are exclusively enantiomeric. Indeed, common chiral selectors are cyclodextrins used in capillary electrophoresis. Macrocyclic antibiotics and crown ethers are commonly used selectors. Selectors may be used either globally or in zones of an array of the present invention to confer yet another means of separation.
For the purposes of the present invention, the term “capillary electrophoresis separation process” refers to a separation process in which separation takes place in a liquid rather than in a gel matrix. Capillary electrophoresis allows for separations to be done on smaller quantities of material and with improved resolution in comparison to conventional gel electrophoresis processes. The channels in an array of the present invention may be arranged to generate a capillary type arrangement in a second direction following separations based on chemical properties (e.g., IEF, affinity, hydrophobic interaction chromatography or enantiomeric separation) or capillaries may be applied as a third dimension.
For the purposes of the present invention, the phrase “comprises Si” refers to silicon and any silicon complex, compound, etc. that includes silicon, such as SiO2, glass, etc.
For the purposes of the present invention, the term “lipid” refers to conventional lipids, phospholipids, etc.
For the purposes of the present invention, the term “lipid bilayer” refers to any double layer of oriented amphipathic lipid molecules in which the hydrocarbon tails face inward to form a continous continuous nonpolar phase.
For the purposes of the present invention, the term “simple bilayer” refers to a conventional lipid bilayer in which the bilayer is formed from micelles of phospholipids with or without membrane proteins.
For the purposes of the present invention, the term “hybrid bilayer” refers to a bilayer that is derived from more than one source, either through mixing of micelles before formation, or post bilayer fusion. These also refer to bilayers in which one component is synthetically derived, or in which one leaflet is supported on the nanotextured surface prior to bilayer formation.
For the purposes of the present invention, the term “self-assembled monolayer hybrid bilayer” refers to a hybrid bilayer in which the synthetic portion is composed of a self-assembled monolayer of silanes or ω-substituted alkanethilates on gold.
For the purposes of the present invention, the term “suspended” refers to bilayers present on a nanostructure and located above nanotroughs in a nanostructure. An example of a suspended bilayer is shown in FIGS. 9, 10 and 11.
For the purposes of the present invention, the term “supported” refers to bilayers located in nanotroughs of a nanostructure. An example of a supported bilayer is shown in FIG. 12.
For the purposes of the present invention, the term “nanotrough” refers to a trough with a void dimension of 1-500 nm, whether uniform or not.
For the purposes of the present invention, the term “leaflet” refers to one half of a fluid bilayer membrane composed of a single layer of phospholipids and any included proteins.
For the purposes of the present invention, the term “filled with at least one fluid” refers to a nanostructure, preferably a nanotrough or channel, containing a fluid that is at least partially contained within said nanostructure. The nanostructure does not need to be completely filled with a fluid according to this definition.
For the purposes of the present invention, the term “membrane associated biomolecule” refers to any membrane associated biomolecule, such as transmembrane proteins, membrane phospholipids, lipophilic biomolecules, complexes thereof, etc.
Description
The present invention provides, in part, for robust, inexpensive and reproducible methods for forming separation matrices for gradient separations based on, for example, electrophoresis and size exclusion that includes all the positive traits of gradient PAGE. These matrices may be adapted for a host of variant separation strategies, including electrophoresis, detergent solubilization, native electrophoresis, isoelectric focusing, 2D-electrophoresis, hydrophobic interaction, and affinity chromatography. More specifically, the present invention provides for the use of such separation matrices as support for lipid bilayers that serve as separation platforms for membrane-associated biomolecules. The methods of fabrication discussed herein may also be adapted to existing microfabrication and integration facilities.
The present invention provides for separation of molecular species across a nanostructured matrix, a method of fabricating nanostructures comprising the matrix and the use of such a matrix for separation and/or analysis of molecules by defining the physical size and/or chemical features of the nanostructures as a means of screening. The nanostructured matrix may be used to separate biological materials, such as proteins, carbohydrates, and nucleic acids as well as nonbiological materials, such as synthetic polymers. These nanostructures may be made out of a variety of materials, including silicon, thus providing systems that may be easily chemically modified for additional flexibility. The use of lithography to generate nanostructured separation matrices has advantages over other techniques (such as traditional acrylamide gel polymerization) since it (1) creates highly ordered structures, (2) gives the possibility of creating macroscopic arrays of continually varying size or chemistry across one dimension, (3) is highly reproducible, and (4) may be easily implemented in the creation of complex, integrated separation systems that are disposable or reusable. Furthermore, the use of lithographically defined separation matrices lends itself to the facile implementation of these matrices into multi-level, 3-dimensional separation devices in which different screening mechanisms allow enhanced separations. Particularly, the lithographic nanostructured surfaces may be used to support lipid bilayers or hybrid lipid bilayers for separating membrane-associated molecules and studying cellular interactions. The present invention aims to (1) eliminate some of the current limitations by the fabrication of highly uniform and reproducible nanostructured separation systems prepared by nano- and microlithography, and (2) eliminate some of the current limitations by utilizing the lithographic nanostructured surfaces in conjunction with lipid bilayers to produce separation platforms for membrane-associated molecules.
Nanolithographically-Defined Gradients:
Using an advanced lithographic technique such as interferometric lithography (IL) capable of producing nanostructures, patterns of nanostructures may be rapidly created over wide, macroscopic areas al low cost (compared to other techniques such as electron beam lithography). In addition, it may be used to easily generate arrays of nanostructures (protrusions or channels) whose dimensions vary semi-continuously in the plane of surface of the material being patterned. IL has advantages over other methods that might be used to construct nanopatterned fluidic structures (e.g., electron beam lithography, X-ray lithography, or local probe lithography) due to the low cost of implementation and the parallel nature of the lithographic technique. Combining IL with conventional lithography allows for the formation of device structures in individual areas and the addition of aperiodic features such as electronic and fluidic connections. Imaging interferometric lithography extends optics to fundamental, deep-subwavelength scales.
It is worthwhile at this point to consider the fundamental limits of optical lithography. For the interference of two plane waves in air, the period is given by λ/(2 sin θ) where λ is the optical wavelength and θ is the angle of incidence. For a 213-nm laser source (fifth harmonic of YAG) this gives a period of ˜150 nm (for θ=80°). FIG. 1 shows an example of a large-area, 150 nm period, photoresist grating. It is important to realize that this limit is on the period, not on the feature dimensions. Nonlinearities in the exposure/develop processes and in subsequent processing may reduce the feature to dimensions well below λ/4. An example in FIG. 2 shows 30-nm developed resist lines on a 360-nm pitch written at a wavelength of 364 nm. The ultimate limit in linewidth is set by material properties and by uniformity of the processing; linewidths as small as 10 nm are routinely achieved. The use of immersion techniques may further reduce the period by a factor of the refractive index, approximately a factor of 1.5, to a period of ˜75 nm. Initial results reproduced the 150 nm pitch of FIG. 1 at a lower angle of incidence.
Water and higher-index liquids, including liquid Ar (n˜1.6), may be used to further extend these results into the sub-100-nm period regime that will be important for biological separations. FIG. 3 shows an initial example of immersion interferometric lithography where the grating period has been reduced to 108 nm with exposure by 213 nm light using immersion in deionized water.
Nonlinear processes may be used to further reduce the period. FIG. 4 shows an example of a photoresist line interpolated between two parallel lines that have already been transferred into a nitride layer. FIG. 5B shows the result of transferring both of these patterns into Si using a KOH etch process. The final period is ˜half of the initial IL period. Extending the calculation above with this spatial period division gives a period of ˜37 nm and a dense linewidth of ˜17 nm (λ/12).
Importantly, all of these results are macroscopic in scale, e.g., covering areas of ˜1 cm2 or larger. A strength of optics is the parallel nature of the exposure, which may be cm's or larger in extent. For a square lattice with a 100-nm pitch and a 1 cm field, there are 1010 features, well beyond the realistic capabilities of serial techniques such as e-beam and scanning probes. In particular embodiments of the present invention, IL may be extended deep into the nanometer regime (either to feature sizes of ˜10 nm or nearest-neighbor distances (aperture sizes) of <10 nm, but not both simultaneously).
A continuously varying channel spacing between nanostructures is desired for many of the bio-separation applications such as various nanofluidic configurations discussed herein.
One approach to a graded structure is to macroscopically vary the intensity across the plane of exposure while keeping the other interference conditions, such as the angles between the light propagation vectors and the polarization, unchanged. One such variation of intensity would be a smooth gradient in intensity of one of the two interfering light waves. This results in interference fringes with uniform spacing but different intensities. The difference in intensity of the fringes leads to differences in exposure of the photoresist used. Because the fringe spacing is not changed, the pitch is uniform. The interference pattern would have even better contrast if both light waves had the same gradient in intensities.
When a positive photoresist is used, the areas corresponding to fringes with stronger intensities leave wider cavities in the photoresist after exposure and developing. The areas corresponding to fringes with weaker intensities leave narrower cavities in the photoresist. When the substrate is etched, these differing widths translate into features in the substrate that have differing widths. The features have the same pitch, however, because the fringe spacing is not altered. This leads to a constant pitch, but a varying line:space ratio. This procedure provides a continuously decreasing channel width that may be accurately controlled over very long distances. Such gradient separation matrices exhibit the favorable traits of gradient gels (high resolution in separation), without the difficulty and irreproducibility associated with their preparation.
Similarly, this technique, when used with a negative photoresist, leaves wider features in the areas corresponding to fringes with weaker intensity and narrower features in the areas corresponding to fringes with stronger intensity.
An alternative approach may produce features with a gradient in width and pitch. This may be easily achieved with IL by using a cylindrical lens in one of the beams, while keeping the other beam as a plane wave. In this case the plane of exposure becomes a chord for a number of circular wavefronts. Because the wavefronts have different radii of curvature (spacing of an optical wavelength), the spacing between the interference fringes, as well as the width of the interference fringes, vary along the length of the plane containing the interference fringes on the surface of the photoresist coating the substrate. Similarly, curved surfaces (sections of Newton's rings) may be formed by interfering a plane wave and a spherical wave or two spherical waves of differing radii of curvature.
Other types of separation systems may involve discontinuous gradients. One such system may have differing aperture sizes that may be produced by separate exposures with different intensities, at different pitches through shadow masks, or by using multiple exposure techniques to eliminate rows and/or columns of pillars in certain areas of a previously exposed uniform nano-structured surface.
Variations in size may also be produced chemically. For example, increasing the oxidation of silicon in certain areas of a chip may result in a swelling of the features, reducing the width of some channels while conserving the pitch of the features. Similarly, macroscopic areas may be selectively functionalized with monolayers, reducing the width of channels in that area.
One may also electrochemically produce silicon carbide on a silicon substrate. Silicon carbide is suitable for sublimation growth, allowing one to control the width of the modified channels in a certain area. Of course, silicon carbide is only one example of surface modifications that may be performed.
One may also selectively heat a substrate, bringing it close to its annealing temperature. At this time the substrate may be placed under a highly controlled stress. The subsequent strain alters the size of channels. A gradient in temperature across the substrate results in a gradient of strain, and therefore a gradient in channel widths. This technique would only be suitable for substrates without a crystalline structure (such as glass or amorphous silicon, for example).
The very high aspect ratios of FIGS. 5A and 5B were achieved using highly anisotropic wet chemical etching of crystalline Si in KOH, which exhibits a >400:1 etch-rate selectivity for etching the <100> plane relative to the <111> plane of Si. Thus, the vertical sidewalk are nearly perfect <111> Si facets. These structures may be further modified by oxidation. This provides insulation between the Si and the surrounding material (allowing electrophoretic fluidic manipulation) and varies the surface interactions between the nanostructure and the surrounding materials for fluidic applications. Very high aspect ratio, crystal-structure-independent etching processes have been developed to address the need for 3D structures in MEMs technology. These involve pulsed gas processes in which an isotropic etch process may be alternated with a surface passivation step to reduce the sidewall etch rate and only etch feature bottoms exposed by ion bombardment. To date, these processes have largely been investigated on micrometer scales. As part of the present invention, these processes are extended to the nanostructured regime. This greatly broadens the available classes of materials for which deep, high aspect ratio structures suitable for nanofluidic applications may be fabricated.
Nanostructures that exhibit a gradient in their capacity to transport biomolecular species (through size exclusion or otherwise) may be created by the IL processes discussed herein. Such gradients make separation matrices feasible for highly efficient separation of molecular species. Molecular species may be driven in the direction of the gradient, and thus separated based on their tendency to traverse the gradient, by a variety of driving forces, including, but not limited to, electrophoresis, externally-applied pressure, capillarity, diffusion, and osmosis.
IL represents a convenient method for generating nanostructured separation matrices that contain physical gradients that allow selective transport of chemical species and, thus, may be used to achieve a separation of different chemicals. When compared to other nanolithographic methods of pattern generation (e.g., electron beam lithography, scanning probe lithography), IL is more convenient, efficient and inexpensive because it may be used to generate the entire pattern in one, parallel step and is not a serial “writing” technique. Other parallel techniques (e.g., imprint lithography) rely on a primary patterning technique to generate a master that may then be used to produce replicas of nanostructured features in a parallel fashion. While IL is a preferred method to generate nanostructured gradients for molecular separation, a variety of methods could be employed to generate the nanostructured matrix gradient “artificial gels” of the present invention. Gradients in the chemistry of the separation matrix may be prepared by a variety of methods as well, including those based on IL.
The use of IL allows such nanostructured separation matrices to be produced easily and very inexpensively. Nanostructures in which channels are on the order of the excluded size of dissolved biomolecules allow an enhanced flexibility in separation. Higher resolution may be obtained in combination with any of the following mechanisms namely, size exclusion, electrophoretic mobility, isoelectric point, asymmetric diffusion, entropic trapping, hydrophobic interaction and affinity interaction (molecular recognition), as well as others. The gradient matrices produced allow efficient separation and identification of biomolecules such as native proteins and protein complexes in addition to denatured proteins and nucleic acids.
Nanolithography-generated systems have advantages over conventional systems in terms of (1) the virtually perfect uniformity of pore size and pore size distribution from device to device, and (2) the flexibility to precisely define the required distribution (gradient) of pore sizes and pore chemistries. This high degree of reproducibility and versatility in nanofabrication will result in the ability to construct separation devices that exhibit unprecedented degrees of flexibility (resolution, dynamic range) and reproducibility in their separation characteristics.
The separation gradient may be formed by a variety of means including, for example, nanolithography (e.g., IL, electron beam, local probe, nanoimprint) and pattern transfer (etching, deposition, lift-off) means.
FIG. 6 shows a schematic of a nanostructured gradient (chirped) separation matrix. The separation gradient may be formed by a variety of means including nanolithography (e.g., IL, electron beam, local probe, nanoimprint) and pattern transfer (etching, deposition, lift-off) means. FIG. 6 illustrates a graded array of nanostructures. The aperture size between the nanostructures approaches molecular dimensions. The arrows signify the direction of movement of molecular species comprising the mixture to be separated and the direction of separation. The height of the nanostructures is preferably sufficiently larger (e.g., 100 nm-1 μm) than the diameter to allow for higher throughput of the separated species.
Multiple-exposure IL moiré patterns provide for cyclic gradients that may be used for simultaneous manufacture of multiple structures. Gradients may also be fabricated across uniform patterns by non-uniform deposition or etching using properly designed deposition and/or etching tools and techniques such as oblique incidence of etch/deposition atomic/molecular species (shadowing). Analogous techniques may be used in generation of gradients in surface modification chemistry incorporated into the array.
FIGS. 7A and 7B show a perspective view and a top view, respectively, of a nanostructured matrix according to the present invention. Matrix 700 has a plurality of protrusions 702. A sample containing some concentration of molecules moves in the direction of arrow 704. The diameter of channel 705 between protrusion 706 and protrusion 708 is larger than the diameter of channel 709 between protrusions 710 and 712. This change provides a gradient such that larger molecules are inhibited from moving the entire length of matrix 700 once the molecules encounter channels between two protrusions that are smaller than the diameter of the molecule. FIGS. 7A and 7B may be extended to formation of channels to delineate the pathway for molecule movement.
FIG. 13 shows a top view, respectively, of a nanostructured matrix according to the present invention. Matrix 1300 has a plurality of protrusions 1302 of a first size and spacing and protrusions 1303 of a second size and spacing. A sample containing some concentration of molecules moves in the direction of arrow 1304. The diameter of channel 1305 between protrusion 1306 and protrusion 1308 is larger than the diameter of channel 1309 between protrusions 1310 and 1312. This change provides a gradient such that larger molecules are inhibited from moving the entire length of matrix 1300 once the molecules encounter channels between two protrusions that are smaller than the diameter of the molecule. Matrix 1300 includes a first region of the gradient having successive rows of protrusions 1302 and channels 1305 therebetween that are substantially the same size. Matrix 1300 includes a second region of the gradient having successive rows of protrusions 1303 and channels 1309 therebetween that are substantially the same size.
As an example of channel formation according to the present invention, IL and anisotropic wet etching of Si allow the creation of open, parallel nanostructured channels (e.g., uncapped in the direction perpendicular to the surface) with lateral features on the order of biomolecular length scales (˜1-10 nm) but with overall dimensions reaching the microscopic (˜100 μm) or even macroscopic (˜1 cm or greater) scales. Depending upon the dimensions, molecular transport mechanisms may include diffusion, electrophoresis or bulkflow. The relatively large vertical scale is sufficient to allow high throughput of molecules and external pumping using either electrokinetic or electro-osmotic forces. Examples of high aspect ratio IL nanostructured samples are shown in FIGS. 8A, 8B and 8C. Such architectures are applicable to channel and post arrays that are of interest for the separation of proteins and large DNA molecules.
Arrays of nanostructures (either of uniform size or with a gradient of sizes) may be surface-modified with chemical species that enhance the separation characteristics of the matrix. These chemical species may be distributed uniformly over the nanostructured separation matrix or may be distributed in a gradient (continuous or discrete) in the direction of separation over the matrix. These chemical species may include small organic molecules, polymers, receptors or other biomolecules.
IL may be used to expose patterns on photoresist on silicon or other materials (which may later be etched). Silicon and some other materials may have an oxide surface that is easily modified with silanization reagents. Synthetic strategies for modification are also available for other materials (besides oxides), including native silicon and noble metals (e.g., gold). Monomolecular layers may be created from a wide range of commercially- or synthetically-available chemical species that may enhance separation characteristics based on the type and degree of interaction of chemical species being separated with the walls of the surface-modified nanostructured separation matrix. Examples of types of surface modifications (either as gradients or uniform) include the use of hydrophilic oligomeric and polymeric species (e.g., poly-ethylene glycol (PEG)) to minimize interactions of chemical species, especially proteins, with nanostructured surfaces; use of hydrophobic molecular or oligomeric species to elicit hydrophobic interaction of chemical species (especially proteins) with nanostructured surfaces; use of mixtures of hydrophobic and hydrophilic species (polar, apolar, H-bonding, ionic) to tune interaction of different chemical species with surfaces; use of ionic molecular species and mixtures of ionic species to tune interaction of different chemical species with surfaces; use of biomolecular or organic receptors to elicit molecular recognition of small molecules, polymers, proteins, DNA, RNA, or oligonucleotides with the surface; use of oligonucleotide probes to tune interactions of DNA, RNA or nucleic-acid binding proteins with the surface; use of cyclodextrins, macrocyclic antibiotics, crown ethers and other chiral selectors to tune enantiomeric interactions of chemical species with the surface; and use of stimuli-responsive (smart) molecules or polymers to allow external control of interaction of chemical species with the nanostructured surface.
Other types of separation systems of the present invention may be thought of as having discontinuous gradients. These separation systems contain areas with different aperture sizes, and may be made either by separate exposures at different intensity, at different pitches through shadow masks, or by using multiple exposure techniques to eliminate rows and/or columns of pillars. Such systems are especially useful in that they will allow recovery of separated compounds (purification).
Microfabricated Integrated Multi-Dimensional, Multi-Technique Separation Systems
The present invention allows a variety of different separation strategies (electrophoresis, iso-electric focusing, affinity chromatography, hydrophobic interaction chromatography, enantiomeric resolution) to be used on a single monolithic device, thus allowing for ease of use and compactness of instrumentation.
The closest existing commonly used multi-technique separation is two-dimensional gel electrophoresis (2DGE). In traditional 2DGE, proteins are first separated according to isoelectric point, followed by resolution by mass-to-charge-ratio using standard polyacrylamide electrophoresis. This process requires that two separate electrophoretic procedures be performed, each requiring manipulation of the sample. A nanostructured matrix of the present invention allows for sequential analysis on a single chip, thus reducing sample loss and diffusion. The wide range of chemical modifications and array architecture allowed by IL devices will also permit separation of proteins by means in addition to size and isoelectric point, either by appropriate chemical patterning and valving of the device, or by addition of a third separation and/or dilution dimension.
Fabrication of separation matrix systems from materials (e.g., Si and quartz) commonly used in the fabrication of integrated circuits is advantageous. They have unique etching and surface modification characteristics that are well established, and may be easily implemented in existing microfabrication facilities for the development of complex separation and detection systems. Other materials with advantageous characteristics may also be used.
The nanostructured matrix of the present invention may be used for two-dimensional gel electrophoresis, and a number of other separation techniques may be combined with size exclusion and/or isoelectric focusing. In addition, the matrix has the capability of expansion beyond two dimensions.
Combining two or more standard types of analysis on a single platform may enhance the analytical potential of a nanostructured matrix of the present invention. Among the possible combinations of separation technologies applicable to this platform are those analogous to PAGE, isoelectric focusing, hydrophobic interaction chromatography, affinity chromatography, enantiomeric resolution and capillary electrophoresis. The matrix lends itself well to carrying out equivalent molecular weight separations, with either electrical currents or flow as the driving force.
The present invention may be useful in proteomics by enabling combinations of different types of analysis, e.g., size exclusion in one dimension with chemical differentiation in the second. A third dimension, oriented perpendicular to the two dimensional array, may then be used for further separation, or for recovery and further characterization of isolated spots.
The present invention may also find use in protein separations for forensic and medical diagnostic tools and in the separation of bioengineered proteins. Forensic analysis and diagnostics, for example, depend heavily upon differentiation between carbohydrate moieties on blood proteins and bacterial cells. Discovery of clinically useful drugs often depends on identifying interactions with specific cellular receptors, which are usually glycoproteins. Capillary electrophoresis has been extremely useful in separations of acid carbohydrates, with derivatization of the column. The present invention allows for the separation of two properties, for example glycoprotein size and carbohydrate content on a single platform, thus eliminating the need for cumbersome recovery between steps and increasing the yield of useful analyte.
Recently, techniques utilizing antibody-based affinity separations have transitioned from clinical laboratories to those for environmental monitoring. The present invention allows sequential analysis of at least two different properties, thus increasing sensitivity of analysis, with particular interest for environmental monitoring.
The present invention allows for separation of a variety of sizes of nucleic acid species, and thus, may be used for separations that are currently done by standard and pulsed-field gel electrophoresis, as well as nucleic acid sequencing. In addition, modification of the device by nucleic acid-binding molecules (e.g., proteins, drugs) allows for isolation of relevant target sequences from previously uncharacterized genomes, or for isolation of a biocomplex formed with a nucleic acid. Because separation may be multidimensional, these devices may be attached in series with a reaction chamber (for example, a PCR thermocycler) and the resultant product directly fed into the separation platform for purification and analysis in a single device.
IL may be used to create nanostructures on a variety of substrates. IL, in combination with other standard lithographic and microfabrication methodologies, may be used to create a variety of nanostructures that may be modified in many ways to produce tools for separation of relevant biomolecules. These have advantages over contemporary molecular separation systems because they exhibit superior performance (resolution, sensitivity, dynamic range, applicability, reproducibility), may be parallel-produced at relatively low cost, and are extremely flexible in terms of chemical modifications. They have defined features that may be reproducibly made, enable flexible and complex separation, and may be used with existing bioseparation and detection strategies.
Supported and Suspended Lipid Bilayers on Nanotextured Surfaces
An additional aspect of the present invention is the use of defined lithographic nanostructures to suspend or support lipid bilayers and hybrid lipid bilayers as a separation platform for membrane-associated biomolecules. This invention expands upon previous methods for (1) incorporating lipid bilayers and nanostructured surfaces for separation techniques, and (2) creating lipid bilayers in which regions of the lipid bilayers are freely suspended or supported between two aqueous reservoirs. Specifically, the present invention utilizes suspended or supported lipid bilayer architecture in the separation of transmembrane molecules.
FIG. 9 shows lipid bilayer 902 suspended on nanostructure 904. The dimensions of nanotroughs 906 are such that lipid bilayer 902 may be suspended on nanostructure 904 over the nanotrough, allowing for domains of biomolecules 908 exterior to the membrane to segregate into these troughs for separation. These structures are made by spontaneous assembly of lipid bilayers from lipid micelles on a hydrophilic surface. Transmembrane proteins and other biomolecules may be incorporated either during the formation of the micelles or formation of the membrane through fusion of micelles incorporating them or membrane ghosts. Certain membrane proteins are also capable of self-directed insertion into the membrane and these may be incorporated by direct insertion into the membrane.
FIGS. 10, 11 and 12 show various bilayers that may be associated with a particular nanostructure according to embodiments of the present invention. FIG. 10 shows a generic bilayer 1002 suspended on nanostructure 1004 over nanotroughs 1006. FIG. 11 shows a suspended lipid/self-assembled monolayer hybrid bilayer 1102 on nanostructure 1104 having nanotroughs 1106. This bilayer type of structure forms spontaneously when a monolayer containing hydrocarbon-like chains are present on the nanostructures. In this configuration, fluidity of the lower leaflets in the supported region is lost, as that leaflet is fixed. Transmembrane proteins and other membrane biomolecules are expected to move preferentially in those areas with greatest total membrane fluidity, i.e. in the troughs. It is also anticipated by the present invention that given formation conditions, e.g. size and curvature of the forming micelles in relation to the nanoarchitedure, that one may also achieve coverage of the bilayers over the entire surface, or over selected surfaces of the nanosupport. An example is represented in FIG. 12, which shows bilayer 1202 supported in nanotroughs 1206 in nanostructure 1204. This sort of structure may be achieved through selective modification of the tops of the nanostructures such that they would not support bilayer formation (e.g., hydrophobic modification) and through use of micelles that are smaller than the diameter of the nanotrough.
Of particular interest are nanofabricated arrays of structures that exhibit a gradient in their capacity to transport molecules. The reason being that such gradients allow for separation matrices that eliminate the requirement for detergent solubilization, and thus denaturation, of transmembrane biomolecules prior to separation, which is the current state of the art. Such gradient structures allow molecular species to be driven in the direction of the gradient, thereby separating the molecules based on their tendency to traverse the gradient. Molecular species may be driven across the gradient by forces such as electrophoresis, externally-applied pressure, capillarity, diffusion, and osmosis. Depending on the desired means of separation, several modifications of the nanostructured support that will enhance separation within the supported or suspended bilayer are envisioned. These include, but are not limited to chemical modifications, such as changes in hydrophobicity, charge, or dipole moment which will allow interactions with protein domains exterior to the bilayer, modification with ligands or other biomolecules that have the potential for interacting with a target class of membrane proteins, and other modifications that end users will deem necessary to base separations on membrane protein function.
Two relevant methods for fabricating suspended lipid bilayers have been reported: (1) suspending small unilamellar vesicles that are made and applied directly to an unmodified Si surface, and (2) generating large unilamellar vesicles with direct pipetting of these structures onto a surface. See, Groves, J. T., Wulfing, C., and Boxer, S. G., Electrical manipulation of glycan phosphatidyl inositol tethered proteins in planar supported bilayers, Biophysical Journal, 71: 2716-2723 (1996), and Menger, F. M., and Angelova, M. I., Accounts of Chemical Research, 31: 789-797 (1999), the entire contents and disclosures of which are hereby incorporated by reference. Preliminary studies included forming suspended lipid bilayers to examine their applicability in the present invention.
Since the electrophoretic mobility of transmembrane molecules across suspended lipid bilayers depends on (1) the molecule's mass to charge ratio, and (2) the size of the extramembrane domains relative to the corrugated apertures in the nanostructured support, it is necessary to fabricate a device that allows for preferential movement of molecules. An embodiment of the present invention suspends lipid bilayer membranes over a series of small gaps, approximately 100 nm in size, and utilizes the entire supported membrane as a separation and analysis platform. The small sizes of the gaps between features allows the lipid bilayer membrane to be suspended over the gaps, which allows for preferential movement of membrane phospholipids, transmembrane proteins, and other lipophilic biomolecules, and their complexes. More specifically, the relative fluidity of the lower leaflet of the lipid bilayer in the suspended regions, and resultant lack of steric hindrance of extramembrane protein domains, results in greater mobility of transmembrane molecules. Furthermore, by making the aperture size on the order of the molecular size of the transmembrane molecules, separations may be based on molecular filtering mechanisms in addition to electrophoretic mobility. Because the areas scanning the gaps may be supported on the underside by aqueous media, more room may also be available for intercellular domains. In addition, biophysical studies both of interactions between extra and intercellular domains of a single protein, and/or of interactions between intercellular domains of proteins within the same membrane are provided by the present invention. Thus, suspended lipid bilayer membranes offer several advantages over the current state of the art, particularly in regard to the separation and concentration of transmembrane proteins.
In a modification of the suspended lipid bilayer model, alkane-chain terminated self-assembled monolayers may be formed on the top surfaces of the nanostructured surfaces, either by silane modification of Si substrates or ω-substitued ω-substituted alkanethiols on, for example, gold. It is anticipated that these structures may provide even greater mobility of lipophilic biomolecules in supported and non-supported regions of the lipid bilayer membrane due to the immobility of the chemically fixed lower leaflet in the hybrid region.
Several nanotextured surfaces have also been explored. IL may produce a variety of features, including posts and grooves, in nearly infinite combinations of types and arrangements. Such features may be arranged in a regular array, thus mimicking standard gels, with the features either shaped or arranged in an asymmetric manner, or as semidiscontinuous, or chirped, arrays that vary in their size and/or separation distance along the direction of separation. Furthermore, a combination of grooves and/or posts may be arranged to achieve configurations that allow for two-dimensional separations. The present invention may be used for separation of membranes from osmotically disrupted cells (cell ghosts). This is particularly significant because no previous isolation of membrane-associated biomolecules is necessary, thus preserving the biomolecules' native conformations and complexes.
Although the present invention is primarily concerned with the structures described above, the nanostructured surfaces and lipid bilayer membranes may be combined in such a way to modify only the tops of the features, the lower surface of the nanostructured surface, the sides of the features, or any combination thereof. In addition, lipid bilayer membranes containing different molecules, or derived from different organelles within a cell, may be patterned on the nanostructured surface, thereby conferring a certain level of selectivity within the membrane itself, either due to innate properties of the molecules or the presence of interactive biomolecules within a region of the pattern. Thus, the present invention may be utilized in several manners to facilitate the study of biomolecules.
For instance, the nanostructured surfaces supporting lipid bilayer membranes may be utilized in biophysics to study membrane components. Because, within the suspended regions, neither leaflet of the membrane may be immobilized on the surface, total membrane fluidity may be increased, thus allowing for greater mobility of embedded biomolecules and creating an experimental milieu more closely replicating that found in the cell. Furthermore, interactions between cytoplasmic and extracellular domains may be more easily studied.
In addition, the present device shows promise as a biosensor device. Because the structure allows for proper orientation of the intercellular domains of transmembrane proteins, natural or engineered receptor proteins may take advantage of naturally occurring transduction mechanisms to facilitate signal transduction.
The present invention may further be useful in purification. The nanostructured lipid bilayer device may provide a unique platform on which to purify lipophilic membrane biomolecules. Because the components may be applied from membrane cell ghosts or in lipid micelles, the need for harsh and possibly denaturing detergent extraction may be unnecessary. In addition, complexes of associated proteins may be purified intact, thereby improving the study of pharmaceutical agents.
The present device may also be useful in the crystallization of membrane proteins to provide more pertinent information as to the structure and function of the proteins. The nanostructured lipid bilayer device may be manufactured to produce a gradient of features so that the protein in question aggregates at a single band in the device, thereby accumulating at the critical concentration.
Finally, the present invention may allow for greater flexibility in screening potential pharmaceutical agents. The nanostructured lipid bilayer device may facilitate observation of interactions between target transmembrane molecules and potential therapeutic agents within a defined membrane milieu, as well as allow for in vitro study of the resultant interactions between the drug-bound receptor and other components within the target complexes.
The present invention allows for unprecedented advances in the study of biomembranes and their associated molecules. The fact that membrane associated biomolecules may be applied to the present device, either via cell ghosts or vesicles, without first isolating them in aqueous media using detergent solubilization means that native configurations, associations and, thus, functionality may be preserved.
EXAMPLES Example 1
Design and construction of microscale electrophoresis cells incorporated much of the characteristics of the present invention into a compact system. The cell preferably has the following characteristics: (1) electrochemical current and fluid flow is restricted to occur only through the separation matrix; (2) loading and stacking functions are included; (3) monitoring of mobility and biomolecular detection is possible (e.g., through fluorescence imaging); and (4) for certain applications, separated compounds are recoverable. Simple methods have been used for incorporating nanostructured silicon/silica chips into electrophoresis cells that satisfy criteria (1-3) above. For example, simple methods of rapid prototyping of elastomeric gasket materials have been used.
Example 2
Supported phospholipid bilayers (SPBs) of egg phosphatidyl choline (Egg PC) were formed by vesicle fusion on nanostructured silicon wafers containing troughs ˜180 nm in width on a 360 nm pitch. An intercalating dye was introduced, and the membranes were imaged by scanning laser microscopy. The resultant fluorescence micrographs indicated that the SPBs formed uniformly over the surface and simple FRAP measurements indicated that the bilayers were fluid and that recovery of fluorescence was preferentially in the direction parallel to the nanotroughs.
Example 3
Transmembrane or membrane associated proteins may be incorporated into an SPB, from incorporation in the vesicle stage, insertion on the membrane or through incorporation of cell ghosts (i.e., intact membranes isolated from cells or organelles). The architecture and/or chemistry of the underlying nanotextured support would be then used to guide the movement of membrane proteins through the supported or suspended bilayer, either by size exclusion of the trough over which the membrane is supported, or by chemical interactions with modifications on the nanostructured support.
Although the present invention has been fully described in conjunction with the preferred embodiment thereof with reference to the accompanying drawings, it is to be understood that various changes and modifications may be apparent to those skilled in the art. Such changes and modifications are to be understood as included within the scope of the present invention as defined by the appended claims, unless they depart therefrom.

Claims (62)

1. A nanostructured device comprising:
a substrate including at least one nanotrough therein; and
a lipid bilayer suspended over said at least one nanotrough.
2. The nanostructured device of claim 1, wherein said lipid bilayer comprises a simple bilayer.
3. The nanostructured device of claim 1, wherein said lipid bilayer comprises a hybrid bilayer.
4. The nanostructured device of claim 3, wherein said hybrid bilayer comprises a self-assembled monolayer hybrid bilayer.
5. The nanostructured device of claim 1, wherein said at least one nanotrough is filled with at least one fluid.
6. The nanostructured device of claim 1, wherein said nanostructured device further comprises an array of nanostructures arranged so that said array has a gradient property.
7. The nanostructured device of claim 1, wherein said nanostructured device further comprises at least one nanostructured channel.
8. The nanostructured device of claim 1, wherein said substrate comprises Si.
9. The nanostructured device of claim 1, wherein said substrate comprises a semiconductor chip.
10. The nanostructured device of claim 1, wherein said nanostructured device comprises a biochip.
11. A nanostructured device comprising:
a substrate including at least one nanotrough therein; and
at least one lipid bilayer supported in at least one of said at least one nanotroughs so as to allow biomolecules to pass from said at least one lipid bilayer into said at least one respective nanotrough.
12. The nanostructured device of claim 11, wherein said lipid bilayer comprises a simple bilayer.
13. The nanostructured device of claim 11, wherein said lipid bilayer comprises a hybrid bilayer.
14. The nanostructured device of claim 13, wherein said hybrid bilayer comprises a self-assembled monolayer hybrid bilayer.
15. The nanostructured device of claim 11, wherein said nanostructured device further comprises an array of nanostructures arranged so that said array has a gradient property.
16. The nanostructured device of claim 11, wherein said nanostructured device further comprises at least one nanostructured channel.
17. The nanostructured device of claim 11, wherein said substrate comprises Si.
18. The nanostructured device of claim 11, wherein said substrate comprises a semiconductor chip.
19. The nanostructured device of claim 11, wherein said nanostructured device comprises a biochip.
20. A separation method comprising the steps of:
(a) supporting or suspending a lipid bilayer on a substrate; wherein said substrate comprises at least one nanostructure and wherein said lipid bilayer comprises at least one membrane associated biomolecule; and
(b) applying a driving force to said lipid bilayer to separate said at least one membrane associate biomolecule from said lipid bilayer and to drive said at least one membrane associated biomolecule within said lipid bilayer into said at least one nanostructure.
21. The method of claim 20, wherein said at least one nanostructure comprises at least one nanotrough.
22. The method of claim 21, wherein said at least one nanotrough is filled with at least one fluid.
23. The method of claim 20, wherein said at least one nanostructure comprises at least one channel.
24. The method of claim 20, wherein said at least one nanostructure further comprises at least on one protrusion.
25. The method of claim 20, wherein said substrate comprises Si.
26. The method of claim 20, wherein said lipid bilayer comprises a simple bilayer.
27. The method of claim 20, wherein said lipid bilayer comprises a hybrid bilayer.
28. The method of claim 27, wherein said hybrid bilayer comprises a self-assembled monolayer hybrid bilayer.
29. The method of claim 20, wherein said at least one nanostructure comprises an array of nanostructures arranged so that said array has a gradient property.
30. The method of claim 20, wherein said at least one membrane associated biomolecule comprises a transmembrane protein.
31. The method of claim 20, wherein said at least one membrane associated biomolecule comprises a membrane phospholipid.
32. The method of claim 20, wherein said at least one membrane associated biomolecule comprises a lipophilic biomolecule.
33. The method of claim 20, wherein said driving force comprises electrophoresis.
34. The method of claim 20, wherein said driving force comprises an externally applied pressure.
35. The method of claim 20, wherein said driving force comprises capillarity.
36. The method of claim 20, wherein said driving force comprises diffusion.
37. The method of claim 20, wherein said driving force comprises osmosis.
38. A method for separating particles comprising:
(a) providing a substrate and a plurality of structures arranged on said substrate, wherein said structures comprise successive rows of protrusions, said protrusions exhibiting a gradient property across a plane of said substrate and in a direction transverse to the successive rows of protrusions, the protrusions of each row being of substantially the same size across at least a portion of the substrate; and
(b) flowing a plurality of said particles through said structures in said direction transverse to the successive rows of protrusions to effect separation of said plurality of particles based on affinity.
39. The method of claim 38, wherein said separation based on affinity comprises affinity chromatography.
40. The method of claim 39, wherein said separation based on affinity chromatography comprises immunoaffinity.
41. The method of claim 40, wherein said structures further comprise antibodies.
42. The method of claim 39, wherein said structures further comprise enzymes.
43. The method of claim 38, wherein said gradient is discrete.
44. The method of claim 38, wherein said substrate comprises Si.
45. The method of claim 38, wherein said substrate comprises silicon carbide.
46. The method of claim 38, wherein said particles are biomolecules.
47. The method of claim 38, wherein said structures are surface modified.
48. The method of claim 47, wherein the surface modification comprises modification with poly-ethylene glycol.
49. The method of claim 47, wherein the surface modification comprises modification with one or more oligonucleotide probes.
50. The method of claim 47, wherein the surface modification comprises modification with a hydrophobic molecular or oligomeric species.
51. The method of claim 47, wherein the surface modification comprises modification with a chiral selector selected from the group consisting of cyclodextrins, macrocyclic antibiotics and crown ethers.
52. The method of claim 38, wherein separating particles further comprises applying a driving force to induce said flowing of particles.
53. The method of claim 52, wherein said driving force comprises externally applied pressure.
54. The method of claim 52, wherein said driving force comprises capillarity.
55. The method of claim 52, wherein said driving force comprises diffusion.
56. The method of claim 54, wherein said driving force comprises osmosis.
57. The method of claim 38, wherein said gradient property comprises a gradation in protrusion size.
58. The method of claim 38, wherein adjacent protusions in said rows define respective channels or gaps, said gradient property comprising a gradation in channel or gap size.
59. The method of claim 38, wherein protrusions in least one row are of substantially the same size as protrusions in at least one respectively adjacent row.
60. A method for separating particles comprising:
(a) providing a substrate and a plurality of structures arranged on said substrate, wherein said structures comprise successive rows of protrusions and channels or gaps between the protrusions, the protrusions exhibiting a gradient property across a plane of said substrate and in a direction transverse to the successive rows of protrusions, the channels or gaps exhibiting a gradient property across a plane of said substrate and in a direction transverse to the successive rows of protrusions, the protrusions of each row being of substantially the same size across at least a portion of the substrate, the channels or gaps of each row being of substantially the same size across at least a portion of the substrate, protrusions in at least one row being of substantially the same size as protrusions in at least one respectively adjacent row, channels or gaps in at least one row being of substantially the same size as channels or gaps in at least one respectively adjacent row; and
(b) flowing a plurality of said particles through said structures in said direction transverse to the successive rows of protrusions to effect separation of said plurality of particles based on affinity.
61. The method of claim 60, wherein said gradient property comprises a gradation in protrusion size.
62. The method of claim 60, wherein said gradient property comprises a gradation in channel or gap size.
US12/215,893 2001-02-14 2008-06-30 Nanostructured separation and analysis devices for biological membranes Expired - Lifetime USRE41762E1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/215,893 USRE41762E1 (en) 2001-02-14 2008-06-30 Nanostructured separation and analysis devices for biological membranes

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US26836501P 2001-02-14 2001-02-14
US34700202P 2002-01-11 2002-01-11
US10/073,935 US6685841B2 (en) 2001-02-14 2002-02-14 Nanostructured devices for separation and analysis
US10/338,654 US6913697B2 (en) 2001-02-14 2003-01-09 Nanostructured separation and analysis devices for biological membranes
US11/825,298 USRE42315E1 (en) 2001-02-14 2007-07-05 Nanostructured separation and analysis devices for biological membranes
US12/215,893 USRE41762E1 (en) 2001-02-14 2008-06-30 Nanostructured separation and analysis devices for biological membranes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/338,654 Reissue US6913697B2 (en) 2001-02-14 2003-01-09 Nanostructured separation and analysis devices for biological membranes

Publications (1)

Publication Number Publication Date
USRE41762E1 true USRE41762E1 (en) 2010-09-28

Family

ID=27372379

Family Applications (4)

Application Number Title Priority Date Filing Date
US10/338,654 Ceased US6913697B2 (en) 2001-02-14 2003-01-09 Nanostructured separation and analysis devices for biological membranes
US11/825,298 Expired - Lifetime USRE42315E1 (en) 2001-02-14 2007-07-05 Nanostructured separation and analysis devices for biological membranes
US12/215,893 Expired - Lifetime USRE41762E1 (en) 2001-02-14 2008-06-30 Nanostructured separation and analysis devices for biological membranes
US12/217,114 Expired - Lifetime USRE42249E1 (en) 2001-02-14 2008-07-01 Nanostructured separation and analysis devices for biological membranes

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10/338,654 Ceased US6913697B2 (en) 2001-02-14 2003-01-09 Nanostructured separation and analysis devices for biological membranes
US11/825,298 Expired - Lifetime USRE42315E1 (en) 2001-02-14 2007-07-05 Nanostructured separation and analysis devices for biological membranes

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/217,114 Expired - Lifetime USRE42249E1 (en) 2001-02-14 2008-07-01 Nanostructured separation and analysis devices for biological membranes

Country Status (1)

Country Link
US (4) US6913697B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070264675A1 (en) * 2002-09-27 2007-11-15 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US20090109422A1 (en) * 2006-05-12 2009-04-30 Canon Kabushiki Kaisha Detecting element, detecting device and detecting method
US8961764B2 (en) 2010-10-15 2015-02-24 Lockheed Martin Corporation Micro fluidic optic design
US9067207B2 (en) 2009-06-04 2015-06-30 University Of Virginia Patent Foundation Optical approach for microfluidic DNA electrophoresis detection
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
US9541480B2 (en) 2011-06-29 2017-01-10 Academia Sinica Capture, purification, and release of biological substances using a surface coating
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
US10495644B2 (en) 2014-04-01 2019-12-03 Academia Sinica Methods and systems for cancer diagnosis and prognosis

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881198B2 (en) * 2001-01-09 2005-04-19 J. David Brown Glaucoma treatment device and method
US6913697B2 (en) 2001-02-14 2005-07-05 Science & Technology Corporation @ Unm Nanostructured separation and analysis devices for biological membranes
US7419574B2 (en) * 2001-06-20 2008-09-02 Cummings Eric B Dielectrophoresis device and method having non-uniform arrays for manipulating particles
US6863833B1 (en) * 2001-06-29 2005-03-08 The Board Of Trustees Of The Leland Stanford Junior University Microfabricated apertures for supporting bilayer lipid membranes
US9678038B2 (en) 2001-07-25 2017-06-13 The Trustees Of Princeton University Nanochannel arrays and their preparation and use for high throughput macromolecular analysis
CA2454570C (en) * 2001-07-25 2016-12-20 The Trustees Of Princeton University Nanochannel arrays and their preparation and use for high throughput macromolecular analysis
AU2003216175A1 (en) * 2002-02-04 2003-09-02 Colorado School Of Mines Laminar flow-based separations of colloidal and cellular particles
FR2839505B1 (en) * 2002-05-07 2005-07-15 Univ Claude Bernard Lyon METHOD FOR MODIFYING THE PROPERTIES OF A THIN LAYER AND SUBSTRATE USING THE PROCESS
WO2005003722A2 (en) * 2003-06-13 2005-01-13 North Carolina State University Nanotube structures having a surfactant bilayer inner wall coating
US7226540B2 (en) * 2004-02-24 2007-06-05 Becton, Dickinson And Company MEMS filter module
US7384550B2 (en) * 2004-02-24 2008-06-10 Becton, Dickinson And Company Glaucoma implant having MEMS filter module
KR20050093018A (en) * 2004-03-18 2005-09-23 한국과학기술연구원 Efficient 3-d nanostructured membranes
US7323033B2 (en) * 2004-04-30 2008-01-29 Lucent Technologies Inc. Nanostructured surfaces having variable permeability
US7638092B2 (en) * 2004-09-17 2009-12-29 Japan Science And Technology Agency Artificial lipid bilayer membrane lipid substitution method, artificial lipid bilayer membrane obtained by using lipid substitution method, artificial lipid bilayer membrane formation device and ion permeation measuring device
US20060171846A1 (en) * 2005-01-10 2006-08-03 Marr David W M Microfluidic systems incorporating integrated optical waveguides
US7569850B2 (en) * 2005-01-24 2009-08-04 Lawrence Livermore National Security, Llc Lipid bilayers on nano-templates
US7544978B2 (en) 2005-01-24 2009-06-09 Lawrence Livermore National Security, Llc Lipid nanotube or nanowire sensor
US20060219637A1 (en) * 2005-03-29 2006-10-05 Killeen Kevin P Devices, systems and methods for liquid chromatography
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
DE602006012307D1 (en) * 2005-05-20 2010-04-01 Aquaporin Aps MEMBRANE FOR FILTRATION OF WATER
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070059716A1 (en) * 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality
US8123948B2 (en) * 2005-09-20 2012-02-28 Aquaporin A/S Biomimetic water membrane comprising aquaporins used in the production of salinity power
US8123834B2 (en) 2005-10-06 2012-02-28 The Board Of Trustees Of The University Of Illinois High gain selective metal organic framework preconcentrators
US9233846B2 (en) * 2005-10-14 2016-01-12 The Regents Of The University Of California Formation and encapsulation of molecular bilayer and monolayer membranes
US10060904B1 (en) * 2005-10-17 2018-08-28 Stc.Unm Fabrication of enclosed nanochannels using silica nanoparticles
US9487812B2 (en) 2012-02-17 2016-11-08 Colorado School Of Mines Optical alignment deformation spectroscopy
US9885644B2 (en) 2006-01-10 2018-02-06 Colorado School Of Mines Dynamic viscoelasticity as a rapid single-cell biomarker
US8119976B2 (en) * 2007-07-03 2012-02-21 Colorado School Of Mines Optical-based cell deformability
US9878326B2 (en) * 2007-09-26 2018-01-30 Colorado School Of Mines Fiber-focused diode-bar optical trapping for microfluidic manipulation
JP2007298502A (en) * 2006-04-04 2007-11-15 Fujifilm Corp Filter for separating blood cells
WO2008057140A2 (en) * 2006-04-14 2008-05-15 The Board Of Trustees Of The University Of Illinois Rapid metal organic framework molecule synthesis method
US20080160313A1 (en) * 2006-04-26 2008-07-03 Gabriel Lopez Lipid bilayers on nanotextured solid surfaces
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc Use of highly parallel snp genotyping for fetal diagnosis
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8394483B2 (en) 2007-01-24 2013-03-12 Micron Technology, Inc. Two-dimensional arrays of holes with sub-lithographic diameters formed by block copolymer self-assembly
US20100196203A1 (en) 2007-02-20 2010-08-05 Gurdial Singh Sanghera Formation of Lipid Bilayers
US8083953B2 (en) 2007-03-06 2011-12-27 Micron Technology, Inc. Registered structure formation via the application of directed thermal energy to diblock copolymer films
US8557128B2 (en) 2007-03-22 2013-10-15 Micron Technology, Inc. Sub-10 nm line features via rapid graphoepitaxial self-assembly of amphiphilic monolayers
DE102007016699A1 (en) * 2007-04-04 2008-10-09 Synentec Gmbh Biochip for the fluorescence analysis of individual transporters
US8097175B2 (en) 2008-10-28 2012-01-17 Micron Technology, Inc. Method for selectively permeating a self-assembled block copolymer, method for forming metal oxide structures, method for forming a metal oxide pattern, and method for patterning a semiconductor structure
US8294139B2 (en) 2007-06-21 2012-10-23 Micron Technology, Inc. Multilayer antireflection coatings, structures and devices including the same and methods of making the same
US7959975B2 (en) 2007-04-18 2011-06-14 Micron Technology, Inc. Methods of patterning a substrate
US8372295B2 (en) 2007-04-20 2013-02-12 Micron Technology, Inc. Extensions of self-assembled structures to increased dimensions via a “bootstrap” self-templating method
US8404124B2 (en) 2007-06-12 2013-03-26 Micron Technology, Inc. Alternating self-assembling morphologies of diblock copolymers controlled by variations in surfaces
US8080615B2 (en) * 2007-06-19 2011-12-20 Micron Technology, Inc. Crosslinkable graft polymer non-preferentially wetted by polystyrene and polyethylene oxide
US10722250B2 (en) 2007-09-04 2020-07-28 Colorado School Of Mines Magnetic-field driven colloidal microbots, methods for forming and using the same
US20090062828A1 (en) * 2007-09-04 2009-03-05 Colorado School Of Mines Magnetic field-based colloidal atherectomy
DE102007059166A1 (en) * 2007-12-06 2009-06-10 Synentec Gmbh Device for measuring transport systems
GB0724736D0 (en) * 2007-12-19 2008-01-30 Oxford Nanolabs Ltd Formation of layers of amphiphilic molecules
US8123841B2 (en) 2008-01-16 2012-02-28 The Board Of Trustees Of The University Of Illinois Column design for micro gas chromatograph
US8999492B2 (en) 2008-02-05 2015-04-07 Micron Technology, Inc. Method to produce nanometer-sized features with directed assembly of block copolymers
US8101261B2 (en) 2008-02-13 2012-01-24 Micron Technology, Inc. One-dimensional arrays of block copolymer cylinders and applications thereof
US8008032B2 (en) * 2008-02-25 2011-08-30 Cellective Dx Corporation Tagged ligands for enrichment of rare analytes from a mixed sample
US8426313B2 (en) 2008-03-21 2013-04-23 Micron Technology, Inc. Thermal anneal of block copolymer films with top interface constrained to wet both blocks with equal preference
US8425982B2 (en) 2008-03-21 2013-04-23 Micron Technology, Inc. Methods of improving long range order in self-assembly of block copolymer films with ionic liquids
US8269029B2 (en) 2008-04-08 2012-09-18 The Board Of Trustees Of The University Of Illinois Water repellent metal-organic frameworks, process for making and uses regarding same
US8114300B2 (en) 2008-04-21 2012-02-14 Micron Technology, Inc. Multi-layer method for formation of registered arrays of cylindrical pores in polymer films
US8114301B2 (en) * 2008-05-02 2012-02-14 Micron Technology, Inc. Graphoepitaxial self-assembly of arrays of downward facing half-cylinders
US8668833B2 (en) * 2008-05-21 2014-03-11 Globalfoundries Singapore Pte. Ltd. Method of forming a nanostructure
EP2293921A4 (en) * 2008-05-22 2013-05-22 Univ California Membrane precursors and membranes formed therefrom
US9187330B2 (en) 2008-09-15 2015-11-17 The Invention Science Fund I, Llc Tubular nanostructure targeted to cell membrane
EP3378951B1 (en) 2008-09-20 2020-05-13 The Board of Trustees of the Leland Stanford Junior University Noninvasive diagnosis of aneuploidy by sequencing
US20100298453A1 (en) * 2009-01-26 2010-11-25 Invista North America S.A R.L. Board stock foam having biobased content
US20110084026A1 (en) * 2009-06-30 2011-04-14 B.G. Negev Technologies Ltd. Biomimetic membranes, their production and uses thereof in water purification
US9068280B2 (en) 2010-01-05 2015-06-30 The Regents Of The University Of California Droplet bilayer formation using throughput liquid handling techniques
US9605307B2 (en) 2010-02-08 2017-03-28 Genia Technologies, Inc. Systems and methods for forming a nanopore in a lipid bilayer
WO2011097028A1 (en) * 2010-02-08 2011-08-11 Genia Technologies, Inc. Systems and methods for manipulating a molecule in a nanopore
US9678055B2 (en) 2010-02-08 2017-06-13 Genia Technologies, Inc. Methods for forming a nanopore in a lipid bilayer
US20120052188A1 (en) 2010-02-08 2012-03-01 Genia Technologies, Inc. Systems and methods for assembling a lipid bilayer on a substantially planar solid surface
EP2603793A4 (en) * 2010-08-15 2014-03-19 Gpb Scientific Llc Microfluidic cell separation in the assay of blood
US8304493B2 (en) 2010-08-20 2012-11-06 Micron Technology, Inc. Methods of forming block copolymers
US9492952B2 (en) 2010-08-30 2016-11-15 Endo-Surgery, Inc. Super-hydrophilic structures
US20120143228A1 (en) 2010-08-30 2012-06-07 Agency For Science Technology And Research Adhesive structure with stiff protrusions on adhesive surface
EP2444808A1 (en) 2010-10-21 2012-04-25 Fredrik Höök Method for fusion of lipid bilayers
FR2967811B1 (en) * 2010-11-24 2014-01-17 Commissariat Energie Atomique PROCESS FOR FORMING A FIBROUS LAYER
US9581563B2 (en) 2011-01-24 2017-02-28 Genia Technologies, Inc. System for communicating information from an array of sensors
US9150598B2 (en) 2011-10-05 2015-10-06 The Regents Of The University Of California Masking apertures enabling automation and solution exchange in sessile bilayers
US8900963B2 (en) 2011-11-02 2014-12-02 Micron Technology, Inc. Methods of forming semiconductor device structures, and related structures
EP2797607B1 (en) 2011-12-29 2018-11-07 Ethicon, Inc. Adhesive structure with tissue piercing protrusions on its surface
GB201202519D0 (en) 2012-02-13 2012-03-28 Oxford Nanopore Tech Ltd Apparatus for supporting an array of layers of amphiphilic molecules and method of forming an array of layers of amphiphilic molecules
US8986629B2 (en) 2012-02-27 2015-03-24 Genia Technologies, Inc. Sensor circuit for controlling, detecting, and measuring a molecular complex
US8926881B2 (en) 2012-04-06 2015-01-06 DePuy Synthes Products, LLC Super-hydrophobic hierarchical structures, method of forming them and medical devices incorporating them
US8969648B2 (en) 2012-04-06 2015-03-03 Ethicon, Inc. Blood clotting substrate and medical device
US9087699B2 (en) 2012-10-05 2015-07-21 Micron Technology, Inc. Methods of forming an array of openings in a substrate, and related methods of forming a semiconductor device structure
GB201313121D0 (en) 2013-07-23 2013-09-04 Oxford Nanopore Tech Ltd Array of volumes of polar medium
GB201300465D0 (en) 2013-01-11 2013-02-27 Aquaporin As A hollow fiber module having tfc-aquaporin modified membranes
US9759711B2 (en) 2013-02-05 2017-09-12 Genia Technologies, Inc. Nanopore arrays
DK177696B1 (en) 2013-02-25 2014-03-17 Aquaporin As Systems for water extraction
US20150064153A1 (en) 2013-03-15 2015-03-05 The Trustees Of Princeton University High efficiency microfluidic purification of stem cells to improve transplants
CN113512522A (en) 2013-03-15 2021-10-19 普林斯顿大学理事会 Method and apparatus for high throughput purification
EP2971287B1 (en) 2013-03-15 2019-08-14 GPB Scientific, LLC On-chip microfluidic processing of particles
US9229328B2 (en) 2013-05-02 2016-01-05 Micron Technology, Inc. Methods of forming semiconductor device structures, and related semiconductor device structures
US9177795B2 (en) 2013-09-27 2015-11-03 Micron Technology, Inc. Methods of forming nanostructures including metal oxides
US9551697B2 (en) 2013-10-17 2017-01-24 Genia Technologies, Inc. Non-faradaic, capacitively coupled measurement in a nanopore cell array
WO2015085274A1 (en) 2013-12-05 2015-06-11 Centrillion Technology Holdings Corporation Methods for sequencing nucleic acids
US10385335B2 (en) 2013-12-05 2019-08-20 Centrillion Technology Holdings Corporation Modified surfaces
EP3077543B1 (en) 2013-12-05 2019-09-25 Centrillion Technology Holdings Corporation Fabrication of patterned arrays
US11060139B2 (en) 2014-03-28 2021-07-13 Centrillion Technology Holdings Corporation Methods for sequencing nucleic acids
GB201418512D0 (en) 2014-10-17 2014-12-03 Oxford Nanopore Tech Ltd Electrical device with detachable components
US9835538B2 (en) * 2014-11-26 2017-12-05 International Business Machines Corporation Biopolymer separation using nanostructured arrays
EP3103885B1 (en) 2015-06-09 2019-01-30 Centrillion Technology Holdings Corporation Methods for sequencing nucleic acids
US10976232B2 (en) 2015-08-24 2021-04-13 Gpb Scientific, Inc. Methods and devices for multi-step cell purification and concentration
GB201611770D0 (en) 2016-07-06 2016-08-17 Oxford Nanopore Tech Microfluidic device
US10596567B2 (en) * 2017-03-27 2020-03-24 International Business Machines Corporation Microfluidic ratchets for displacing particles
US10969324B2 (en) * 2017-08-16 2021-04-06 Washington University Synthesis, post-modification and separation of biologics using acoustically confined substrates
EP3675876A4 (en) 2017-09-01 2021-06-02 GPB Scientific, Inc. Methods for preparing therapeutically active cells using microfluidics
US20200384440A1 (en) * 2017-11-13 2020-12-10 The Regents Of The University Of California Self-healing macromolecular crystal materials
AU2020239385A1 (en) 2019-03-12 2021-08-26 Oxford Nanopore Technologies Plc Nanopore sensing device and methods of operation and of forming it
WO2021011907A1 (en) 2019-07-18 2021-01-21 Gpb Scientific, Inc. Ordered processing of blood products to produce therapeutically active cells
WO2021133897A1 (en) 2019-12-28 2021-07-01 Gpb Scientific, Inc. Microfluidic cartridges for processing particles and cells

Citations (199)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855133A (en) 1971-12-28 1974-12-17 Sartorius Membranfilter Gmbh Multi-layer filter membrane
US3906929A (en) 1973-11-23 1975-09-23 Lynn Lawrence Augspurger Processes for reproduction of cellular bodies
US4190535A (en) 1978-02-27 1980-02-26 Corning Glass Works Means for separating lymphocytes and monocytes from anticoagulated blood
EP0057907B1 (en) 1981-02-05 1986-12-30 Asahi Kasei Kogyo Kabushiki Kaisha Apparatus for separating blood components
EP0094193B1 (en) 1982-05-10 1987-08-19 Bar-Ilan University System and methods for cell selection
US4801380A (en) 1987-12-23 1989-01-31 The Texas A&M University System Method of producing a silicon film with micropores
US4814088A (en) 1985-08-28 1989-03-21 National Research Council Of Canada Method for the molecular filtration of predominantly aliphatic hydrocarbon liquids
US4814082A (en) 1986-10-20 1989-03-21 Memtec North America Corporation Ultrafiltration thin film membranes
US4906439A (en) 1986-03-25 1990-03-06 Pb Diagnostic Systems, Inc. Biological diagnostic device and method of use
US4915839A (en) 1984-03-15 1990-04-10 Cuno, Incorporated Process for surface modifying a microporous membrane
US4916110A (en) 1988-11-01 1990-04-10 W. L. Gore & Associates, Inc. Microporous catalytic material and support structure
US4935141A (en) 1987-08-31 1990-06-19 Gambro, Dialysatoren Kg Selectively permeable asymmetric membranes suitable for use in hemodialysis and processes for manufacturing such membranes
US4969998A (en) 1984-04-23 1990-11-13 W. L. Gore & Associates, Inc. Composite semipermeable membrane
US4971904A (en) 1987-06-26 1990-11-20 E. I. Du Pont De Nemours And Company Heterogeneous immunoassay
US4977078A (en) 1987-12-22 1990-12-11 Olympus Optical Co., Ltd. Plate substrate immunoassay device and method for performing a multi-test immunoassay on a specimen
US5013337A (en) 1988-12-06 1991-05-07 Uop Process for separating a mixture of molecular species using crystalline microporous metal sulfide compositions
US5019263A (en) 1990-06-05 1991-05-28 Mobil Oil Corp. Membrane composed of a pure molecular sieve
US5130025A (en) 1978-04-20 1992-07-14 Unisearch Limited Membrane separation and purification of compounds
US5145584A (en) 1990-12-05 1992-09-08 Allied-Signal Inc. Processes for using a thin film composite ultrafiltration membrane
US5147606A (en) 1990-08-06 1992-09-15 Miles Inc. Self-metering fluid analysis device
US5204239A (en) * 1990-01-09 1993-04-20 Yeda Research And Development Co., Ltd. Biosensors including lipid bilayer doped with ion channels anchored to a recording electrode by bridging molecules
WO1993022053A1 (en) 1992-05-01 1993-11-11 Trustees Of The University Of Pennsylvania Microfabricated detection structures
US5266207A (en) 1991-04-30 1993-11-30 Techsep Composite nanofiltration membrane
US5296375A (en) 1992-05-01 1994-03-22 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices
US5304487A (en) 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
WO1994029707A1 (en) 1993-06-08 1994-12-22 British Technology Group Usa Inc. Microlithographic array for macromolecule and cell fractionation
US5474675A (en) 1988-11-17 1995-12-12 Herco-Cff Chiralflow Filtertechnik Gmbh Filter separator for separating a composite fluid
US5541072A (en) 1994-04-18 1996-07-30 Immunivest Corporation Method for magnetic separation featuring magnetic particles in a multi-phase system
US5587070A (en) 1990-11-06 1996-12-24 Pall Corporation System for processing biological fluid
US5622831A (en) 1990-09-26 1997-04-22 Immunivest Corporation Methods and devices for manipulation of magnetically collected material
US5637458A (en) 1994-07-20 1997-06-10 Sios, Inc. Apparatus and method for the detection and assay of organic molecules
US5639669A (en) 1995-06-07 1997-06-17 Ledley; Robert Separation of fetal cells from maternal blood
US5674592A (en) 1995-05-04 1997-10-07 Minnesota Mining And Manufacturing Company Functionalized nanostructured films
US5707799A (en) 1994-09-30 1998-01-13 Abbott Laboratories Devices and methods utilizing arrays of structures for analyte capture
US5709943A (en) 1995-05-04 1998-01-20 Minnesota Mining And Manufacturing Company Biological adsorption supports
US5716527A (en) 1994-07-08 1998-02-10 Exxon Research & Engineering Company Zeolite membrane with a selectivity enhancing coating
US5715946A (en) 1995-06-07 1998-02-10 Reichenbach; Steven H. Method and apparatus for sorting particles suspended in a fluid
WO1998010267A1 (en) 1996-09-04 1998-03-12 Technical University Of Denmark A micro flow system for particle separation and analysis
US5750339A (en) 1994-11-30 1998-05-12 Thomas Jefferson University Methods for identifying fetal cells
US5753014A (en) 1993-11-12 1998-05-19 Van Rijn; Cornelis Johannes Maria Membrane filter and a method of manufacturing the same as well as a membrane
DE19712309A1 (en) 1996-11-16 1998-05-20 Nmi Univ Tuebingen Microelement arrangement, method for contacting cells in a liquid environment and method for producing a microelement arrangement
US5770029A (en) 1996-07-30 1998-06-23 Soane Biosciences Integrated electrophoretic microdevices
US5798042A (en) 1994-03-07 1998-08-25 Regents Of The University Of California Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters
US5843767A (en) 1993-10-28 1998-12-01 Houston Advanced Research Center Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions
US5858195A (en) 1994-08-01 1999-01-12 Lockheed Martin Energy Research Corporation Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis
US5858188A (en) 1990-02-28 1999-01-12 Aclara Biosciences, Inc. Acrylic microchannels and their use in electrophoretic applications
US5866345A (en) 1992-05-01 1999-02-02 The Trustees Of The University Of Pennsylvania Apparatus for the detection of an analyte utilizing mesoscale flow systems
US5871650A (en) 1994-07-08 1999-02-16 Exxon Research And Engineering Company Supported zeolite membranes with controlled crystal width and preferred orientation grown on a growth enhancing layer
US5876830A (en) 1995-09-08 1999-03-02 Board Of Regents Of The University Of Colorado Method of assembly of molecular-sized nets and scaffolding
US5891651A (en) 1996-03-29 1999-04-06 Mayo Foundation For Medical Education And Research Methods of recovering colorectal epithelial cells or fragments thereof from stool
US5928880A (en) * 1992-05-01 1999-07-27 Trustees Of The University Of Pennsylvania Mesoscale sample preparation device and systems for determination and processing of analytes
US5935822A (en) * 1995-03-21 1999-08-10 The Regents Of The University Of Colorado Product and process for membrane and soluble polypeptide segregation
US5938923A (en) 1997-04-15 1999-08-17 The Regents Of The University Of California Microfabricated filter and capsule using a substrate sandwich
WO1999044064A1 (en) 1998-02-27 1999-09-02 Cli Oncology, Inc. Method and compositions for differential detection of primary tumor cells and metastatic cells
US5993661A (en) 1997-04-14 1999-11-30 The Research Foundation Of State University Of New York Macroporous or microporous filtration membrane, method of preparation and use
US6022590A (en) 1994-07-14 2000-02-08 Competitive Technologies, Inc. Stepwise formation of multilayered nanostructures from macromolecular precursors
US6043177A (en) 1997-01-21 2000-03-28 University Technology Corporation Modification of zeolite or molecular sieve membranes using atomic layer controlled chemical vapor deposition
US6051372A (en) 1997-09-09 2000-04-18 Nimbus Biotechnologie Gmbh Template induced patterning of surfaces and their reversible stabilization using phase transitions of the patterned material
US6054034A (en) 1990-02-28 2000-04-25 Aclara Biosciences, Inc. Acrylic microchannels and their use in electrophoretic applications
US6060415A (en) 1997-02-10 2000-05-09 National Science Council Aligned molecular sieve crystals grown on anodic alumina membrane
US6074827A (en) 1996-07-30 2000-06-13 Aclara Biosciences, Inc. Microfluidic method for nucleic acid purification and processing
US6090289A (en) 1994-07-08 2000-07-18 Exxon Research & Engineering Co. Molecular sieves and processes for their manufacture
US6100393A (en) 1996-03-15 2000-08-08 Antibioticos, S.A. Process for purifying 7-substituted aminodeacetoxy-cephalosporins through the use of filtration membranes
US6113795A (en) 1998-11-17 2000-09-05 The University Of Kansas Process and apparatus for size selective separation of micro- and nano-particles
US6113794A (en) 1999-01-25 2000-09-05 Kumar; Ashwani Composite solvent resistant nanofiltration membranes
US6132607A (en) 1998-02-20 2000-10-17 The Florida State University System for continuous magnetic separation of components from a mixture
WO2000062931A1 (en) 1999-04-21 2000-10-26 Clinical Micro Sensors, Inc. The use of microfluidic systems in the electrochemical detection of target analytes
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US6156270A (en) 1992-05-21 2000-12-05 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6177373B1 (en) 1996-03-14 2001-01-23 Exxon Chemicals Patents Inc Procedure for preparing molecular sieve films
US6187446B1 (en) 1995-03-29 2001-02-13 Pharmacia Biotech Ab Carrier matrix for integrated microanalysis systems, method for the production thereof and use of the same
US6190638B1 (en) 1996-01-04 2001-02-20 Exxon Chemical Patents Inc. Molecular sieves and process for their manufacture
US6197523B1 (en) 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
US6200765B1 (en) 1998-05-04 2001-03-13 Pacific Northwest Cancer Foundation Non-invasive methods to detect prostate cancer
US6241894B1 (en) 1997-10-10 2001-06-05 Systemix High gradient magnetic device and method for cell separation or purification
US6251691B1 (en) 1996-04-25 2001-06-26 Bioarray Solutions, Llc Light-controlled electrokinetic assembly of particles near surfaces
US6261928B1 (en) 1997-07-22 2001-07-17 Commissariat A L 'energie Atomique Producing microstructures or nanostructures on a support
US6264044B1 (en) 1997-04-11 2001-07-24 Cuno, Inc. Reinforced, three zone microporous membrane
US6265229B1 (en) 1994-03-10 2001-07-24 Oystein Fodstad Method and device for detection of specific target cells in specialized or mixed cell populations and solutions containing mixed cell populations
US6277489B1 (en) 1998-12-04 2001-08-21 The Regents Of The University Of California Support for high performance affinity chromatography and other uses
US6309798B1 (en) 1996-05-08 2001-10-30 Studiengesellschaft Kohle Mbh Lithographical process for production of nanostructures on surfaces
US20010036672A1 (en) 1995-06-29 2001-11-01 Anderson Rolfe C. Integrated nucleic acid diagnostic device
US6315940B1 (en) 1996-11-16 2001-11-13 Nmi Naturwissenschaftliches Und Medizinisches Institut An Der Universitat Tubingen In Reutlingen Microelement device
US6329209B1 (en) * 1998-07-14 2001-12-11 Zyomyx, Incorporated Arrays of protein-capture agents and methods of use thereof
US20020005354A1 (en) 1997-09-23 2002-01-17 California Institute Of Technology Microfabricated cell sorter
WO2002012896A1 (en) 2000-08-08 2002-02-14 Aviva Biosciences Corporation Methods for manipulating moieties in microfluidic systems
US6361958B1 (en) 1999-11-12 2002-03-26 Motorola, Inc. Biochannel assay for hybridization with biomaterial
US6368871B1 (en) 1997-08-13 2002-04-09 Cepheid Non-planar microstructures for manipulation of fluid samples
WO2002028523A2 (en) 2000-09-30 2002-04-11 Aviva Biosciences Corporation Apparatuses containing multiple force generating elements and uses thereof
WO2002030562A1 (en) 2000-10-10 2002-04-18 Aviva Biosciences Corporation An integrated biochip system for sample preparation and analysis
US6387290B1 (en) 1995-06-16 2002-05-14 University Of Washington Tangential flow planar microfabricated fluid filter
US20020058332A1 (en) 2000-09-15 2002-05-16 California Institute Of Technology Microfabricated crossflow devices and methods
EP1221342A2 (en) 2001-01-08 2002-07-10 Becton, Dickinson and Company Method for seperating cells from a sample
US20020108859A1 (en) 2000-11-13 2002-08-15 Genoptix Methods for modifying interaction between dielectric particles and surfaces
US20020115164A1 (en) 2000-11-13 2002-08-22 Genoptix Methods and apparatus for generating and utilizing a moving optical gradient
US20020115163A1 (en) 2000-11-13 2002-08-22 Genoptix Methods for sorting particles by size and elasticity
US6444461B1 (en) 1997-04-04 2002-09-03 Caliper Technologies Corp. Microfluidic devices and methods for separation
US20020123112A1 (en) 2000-11-13 2002-09-05 Genoptix Methods for increasing detection sensitivity in optical dielectric sorting systems
US20020123078A1 (en) 1996-04-25 2002-09-05 Michael Seul Array cytometry
US6450047B2 (en) * 1998-11-09 2002-09-17 Agilent Technologies, Inc. Device for high throughput sample processing, analysis and collection, and methods of use thereof
US20020132315A1 (en) 2000-11-13 2002-09-19 Genoptix Methods and apparatus for measurement of dielectric constants of particles
US20020132316A1 (en) 2000-11-13 2002-09-19 Genoptix Methods and apparatus for sorting of bioparticles based upon optical spectral signature
US6454938B2 (en) 1998-09-17 2002-09-24 Kionix, Inc. Integrated monolithic microfabricated electrospray and liquid chromatography system and method
US6465225B1 (en) 1998-06-29 2002-10-15 Evotec Oai Ag Method and device for manipulating particles in microsystems
US20020172987A1 (en) 1998-02-12 2002-11-21 Terstappen Leon W.M.M. Methods and reagents for the rapid and efficient isolation of circulating cancer cells
WO2003000418A2 (en) 2001-06-20 2003-01-03 Cytonome, Inc. Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system
US6503452B1 (en) 1996-11-29 2003-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biosensor arrays and methods
US6540895B1 (en) 1997-09-23 2003-04-01 California Institute Of Technology Microfabricated cell sorter for chemical and biological materials
US20030072682A1 (en) 2001-10-11 2003-04-17 Dan Kikinis Method and apparatus for performing biochemical testing in a microenvironment
WO2003031938A2 (en) 2001-10-11 2003-04-17 Aviva Biosciences Corporation Methods, compositions, and automated systems for separating rare cells from fluid samples
US20030077292A1 (en) 2001-09-19 2003-04-24 The Regents Of The University Of Michigan Detection and treatment of cancers of the lung
WO2003035894A2 (en) 2001-10-26 2003-05-01 Immunivest Corporation Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
US6570196B1 (en) * 2000-03-22 2003-05-27 Max-Plank-Gesellschaft Zur Forderung Der Wissenschaften Lipid vesicles or lipid bilayers on chips
US6576478B1 (en) 1998-07-14 2003-06-10 Zyomyx, Inc. Microdevices for high-throughput screening of biomolecules
US6596144B1 (en) 1997-05-27 2003-07-22 Purdue Research Foundation Separation columns and methods for manufacturing the improved separation columns
EP1338894A2 (en) 2002-02-26 2003-08-27 Agilent Technologies, Inc. Mobile phase gradient generation microfluidic device
US20030159999A1 (en) 2002-02-04 2003-08-28 John Oakey Laminar Flow-Based Separations of Colloidal and Cellular Particles
WO2003079006A1 (en) 2002-03-20 2003-09-25 Monica Almqvist Microfluidic cell and method for sample handling
US6632619B1 (en) 1997-05-16 2003-10-14 The Governors Of The University Of Alberta Microfluidic system and methods of use
WO2003085379A2 (en) 2002-04-01 2003-10-16 Fluidigm Corporation Microfluidic particle-analysis systems
US6635163B1 (en) 1999-06-01 2003-10-21 Cornell Research Foundation, Inc. Entropic trapping and sieving of molecules
US6641997B1 (en) * 1998-03-20 2003-11-04 The Rockefeller University Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
US6664104B2 (en) 1999-06-25 2003-12-16 Cepheid Device incorporating a microfluidic chip for separating analyte from a sample
WO2004004906A1 (en) 2002-07-03 2004-01-15 Nanostream, Inc. Microfluidic closed-end metering systems and methods
US20040018116A1 (en) 2002-07-26 2004-01-29 Desmond Sean M. Microfluidic size-exclusion devices, systems, and methods
US6685841B2 (en) 2001-02-14 2004-02-03 Gabriel P. Lopez Nanostructured devices for separation and analysis
WO2004015411A1 (en) 2002-08-08 2004-02-19 Nanostream, Inc. Systems and methods for high-throughput microfluidic sample analysis
WO2004024327A1 (en) 2002-09-12 2004-03-25 Intel Corporation Microfluidic apparatus with integrated porous-substrates/sensor for real-time(bio)chemical molecule detection
WO2004029221A2 (en) 2002-09-27 2004-04-08 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US20040072278A1 (en) 2002-04-01 2004-04-15 Fluidigm Corporation Microfluidic particle-analysis systems
WO2004037374A2 (en) 2002-10-23 2004-05-06 The Trustees Of Princeton University Method for continuous particle separation using obstacle arrays asymmetrically aligned to fields
EP1418003A1 (en) 2002-10-31 2004-05-12 Hewlett-Packard Development Company, L.P. Microfluidic pumping system
US6746503B1 (en) 2003-01-30 2004-06-08 The Regents Of The University Of California Precision gap particle separator
US20040121343A1 (en) 2002-12-24 2004-06-24 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
WO2004056978A1 (en) 2002-12-19 2004-07-08 Ivonex Gmbh Method for the separation of cell fractions
US6762059B2 (en) 1999-08-13 2004-07-13 U.S. Genomics, Inc. Methods and apparatuses for characterization of single polymers
US6783647B2 (en) 2001-10-19 2004-08-31 Ut-Battelle, Llc Microfluidic systems and methods of transport and lysis of cells and analysis of cell lysate
EP1462800A1 (en) 2001-12-11 2004-09-29 Netech Inc. Blood cell separation system
EP0919812B1 (en) 1997-11-22 2004-10-06 Wardlaw, Stephen Clark Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hemotologic progenitor cells in whole blood
US6815664B2 (en) 2001-04-27 2004-11-09 Genoptix, Inc. Method for separation of particles
US6818184B2 (en) 2000-08-31 2004-11-16 The Regents Of The University Of California Capillary array and related methods
US20040232074A1 (en) 2003-03-21 2004-11-25 Ralf-Peter Peters Microstructured separating device and microfluidic process for separating liquid components from a particle-containing liquid
US20040245102A1 (en) 2002-09-09 2004-12-09 Gilbert John R. Implementation of microfluidic components, including molecular fractionation devices, in a microfluidic system
WO2004113877A1 (en) 2003-06-13 2004-12-29 The General Hospital Corporation Microfluidic systems for size based removal of red blood cells and platelets from blood
US20050049793A1 (en) 2001-04-30 2005-03-03 Patrizia Paterlini-Brechot Prenatal diagnosis method on isolated foetal cell of maternal blood
US6878271B2 (en) 2002-09-09 2005-04-12 Cytonome, Inc. Implementation of microfluidic components in a microfluidic system
US6881315B2 (en) 2001-08-03 2005-04-19 Nec Corporation Fractionating apparatus having colonies of pillars arranged in migration passage at interval and process for fabricating pillars
US20050092662A1 (en) 2002-09-09 2005-05-05 Cytonome, Inc. Implementation of microfluidic components in a microfluidic system
WO2005043121A2 (en) 2003-10-31 2005-05-12 Vitatex, Inc. Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
US6893881B1 (en) 1992-09-14 2005-05-17 Abbott Laboratories, Inc. Method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
WO2005047529A1 (en) 2003-11-04 2005-05-26 Aviva Biosciences Corporation Methods, compositions, and automated systems for separating rare cells from fluid samples
WO2005049168A2 (en) 2003-11-17 2005-06-02 Immunivest Corporation Method and apparatus for pre-enrichment and recovery of cells from densified whole blood
US20050123454A1 (en) 2003-12-08 2005-06-09 David Cox Microfluidic device and material manipulating method using same
US6911345B2 (en) 1999-06-28 2005-06-28 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US20050142663A1 (en) 2003-12-24 2005-06-30 3M Innovative Properties Company Methods for nucleic acid isolation and kits using a microfluidic device and concentration step
WO2005058937A2 (en) 2003-12-12 2005-06-30 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
US6913697B2 (en) 2001-02-14 2005-07-05 Science & Technology Corporation @ Unm Nanostructured separation and analysis devices for biological membranes
WO2005068503A2 (en) 2004-01-07 2005-07-28 Chiron Corporation M-csf-specific monoclonal antibody and uses thereof
US20050164158A1 (en) 2000-11-28 2005-07-28 The Regents Of The University Of California, A California Corporation Microfluidic sorting device
US20050170418A1 (en) 2005-02-18 2005-08-04 John Moreland Microfluidic platform of arrayed switchable spin-valve elements for high-throughput sorting and manipulation of magnetic particles and biomolecules
US20050170373A1 (en) 2003-09-10 2005-08-04 Althea Technologies, Inc. Expression profiling using microarrays
US20050175996A1 (en) 2001-05-09 2005-08-11 Xiangning Chen Multiple sequencible and ligatible structures for genomic analysis
US20050191636A1 (en) 2004-03-01 2005-09-01 Biocept, Inc. Detection of STRP, such as fragile X syndrome
WO2005085861A2 (en) 2004-03-03 2005-09-15 Oridis Biomed Forschungs- Und Entwicklungs Gmbh Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer
WO2005084374A2 (en) 2004-03-03 2005-09-15 The General Hospital Corporation Magnetic device for isolation of cells and biomolecules in a microfluidic environment
US20050211556A1 (en) 2004-03-25 2005-09-29 Childers Winthrop D Method of sorting cells on a biodevice
US20050239101A1 (en) 2003-10-28 2005-10-27 The Johns Hopkins University School Of Medicine Quantitative multiplex methylation-specific PCR
US20050236314A1 (en) 2003-05-20 2005-10-27 Neyer David W Variable flow rate injector
US6960449B2 (en) 1999-02-10 2005-11-01 Cell Works Diagnostics, Inc. Class characterization of circulating cancer cells isolated from body fluids and methods of use
US20050244843A1 (en) 2001-11-16 2005-11-03 Wen-Tien Chen Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
US20050250111A1 (en) 2004-05-05 2005-11-10 Biocept, Inc. Detection of chromosomal disorders
WO2005109238A2 (en) 2004-05-03 2005-11-17 Cygene Laboratories, Inc. Method and system for a comprehensive knowledge-based anonymous testing and reporting, and providing selective access to test results and report
US20050252840A1 (en) 2004-05-13 2005-11-17 Eksigent Technologies, Llc Micromixer
WO2005108621A1 (en) 2004-04-30 2005-11-17 Yale University Methods and compositions for cancer diagnosis
US20050262577A1 (en) 2002-09-27 2005-11-24 Christian Guelly Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
WO2005121362A2 (en) 2004-06-14 2005-12-22 Inserm (Institut National De La Sante Et De La Recherche Medicale Method for selectively quantifying vegf isoforms in a biological sample and uses thereof.
US20060051265A1 (en) 2004-09-08 2006-03-09 Health Research, Inc. Apparatus and method for sorting microstructures in a fluid medium
US20060160243A1 (en) 2005-01-18 2006-07-20 Biocept, Inc. Recovery of rare cells using a microchannel apparatus with patterned posts
WO2006078470A2 (en) 2005-01-18 2006-07-27 Biocept, Inc. Cell separation using microchannel having patterned posts
US20060223178A1 (en) 2005-04-05 2006-10-05 Tom Barber Devices and methods for magnetic enrichment of cells and other particles
US20060252054A1 (en) 2001-10-11 2006-11-09 Ping Lin Methods and compositions for detecting non-hematopoietic cells from a blood sample
US20060252087A1 (en) 2005-01-18 2006-11-09 Biocept, Inc. Recovery of rare cells using a microchannel apparatus with patterned posts
US20070026413A1 (en) 2005-07-29 2007-02-01 Mehmet Toner Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026417A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026415A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026381A1 (en) 2005-04-05 2007-02-01 Huang Lotien R Devices and methods for enrichment and alteration of cells and other particles
US20070026469A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026418A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026419A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026416A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026414A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070059683A1 (en) 2005-09-15 2007-03-15 Tom Barber Veterinary diagnostic system
US20070059716A1 (en) 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality
US20070059680A1 (en) 2005-09-15 2007-03-15 Ravi Kapur System for cell enrichment
US20070059718A1 (en) 2005-09-15 2007-03-15 Mehmet Toner Systems and methods for enrichment of analytes
US20070059781A1 (en) 2005-09-15 2007-03-15 Ravi Kapur System for size based separation and analysis
US20070059774A1 (en) 2005-09-15 2007-03-15 Michael Grisham Kits for Prenatal Testing
US20070059719A1 (en) 2005-09-15 2007-03-15 Michael Grisham Business methods for prenatal Diagnosis
US20070099207A1 (en) 2005-04-05 2007-05-03 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737268A (en) 1986-03-18 1988-04-12 University Of Utah Thin channel split flow continuous equilibrium process and apparatus for particle fractionation
US5193688A (en) 1989-12-08 1993-03-16 University Of Utah Method and apparatus for hydrodynamic relaxation and sample concentration NIN field-flow fraction using permeable wall elements
US5131998A (en) * 1990-11-13 1992-07-21 The University Of North Carolina At Chapel Hill Two-dimensional high-performance liquid chromatography/capillary electrophoresis
WO1995008637A1 (en) 1993-09-21 1995-03-30 Washington State University Research Foundation Immunoassay comprising ligand-conjugated, ion channel receptor immobilized in lipid film
US5728457A (en) * 1994-09-30 1998-03-17 Cornell Research Foundation, Inc. Porous polymeric material with gradients
US5500071A (en) * 1994-10-19 1996-03-19 Hewlett-Packard Company Miniaturized planar columns in novel support media for liquid phase analysis
WO1997001755A2 (en) * 1995-06-26 1997-01-16 Perseptive Biosystems, Inc. High speed, automated, continuous flow, multi-dimensional molecular selection and analysis
US5646048A (en) * 1995-07-24 1997-07-08 Hewlett-Packard Company Microcolumnar analytical apparatus with microcolumnar flow gating interface and method of using the apparatus
SE9602545L (en) * 1996-06-25 1997-12-26 Michael Mecklenburg Method of discriminating complex biological samples
BR9710054A (en) * 1996-06-28 2000-01-11 Caliper Techn Corp Apparatus for separating test compounds for an effect on a biochemical system and for detecting a effect of a test compound on a biochemical system, procedures for determining whether a sample contains a compound capable of affecting a biochemical system, for separating a plurality of test compounds for an effect on a biochemical system and uses of a microfluidic system and a test substrate.
US6699719B2 (en) * 1996-11-29 2004-03-02 Proteomic Systems, Inc. Biosensor arrays and methods
US6406632B1 (en) * 1998-04-03 2002-06-18 Symyx Technologies, Inc. Rapid characterization of polymers
US6210570B1 (en) * 1998-08-21 2001-04-03 Agilent Technologies, Inc. Monolithic silica column
US6377057B1 (en) * 1999-02-18 2002-04-23 The Board Of Trustees Of The Leland Stanford Junior University Classification of biological agents according to the spectral density signature of evoked changes in cellular electric potential
US6998251B2 (en) * 2001-01-12 2006-02-14 Syngenta Participations Ag Nanoporous membrane reactor for miniaturized reactions and enhanced reaction kinetics

Patent Citations (223)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855133A (en) 1971-12-28 1974-12-17 Sartorius Membranfilter Gmbh Multi-layer filter membrane
US3906929A (en) 1973-11-23 1975-09-23 Lynn Lawrence Augspurger Processes for reproduction of cellular bodies
US4190535A (en) 1978-02-27 1980-02-26 Corning Glass Works Means for separating lymphocytes and monocytes from anticoagulated blood
US5130025A (en) 1978-04-20 1992-07-14 Unisearch Limited Membrane separation and purification of compounds
EP0057907B1 (en) 1981-02-05 1986-12-30 Asahi Kasei Kogyo Kabushiki Kaisha Apparatus for separating blood components
EP0094193B1 (en) 1982-05-10 1987-08-19 Bar-Ilan University System and methods for cell selection
US4915839A (en) 1984-03-15 1990-04-10 Cuno, Incorporated Process for surface modifying a microporous membrane
US4969998A (en) 1984-04-23 1990-11-13 W. L. Gore & Associates, Inc. Composite semipermeable membrane
US4814088A (en) 1985-08-28 1989-03-21 National Research Council Of Canada Method for the molecular filtration of predominantly aliphatic hydrocarbon liquids
US4906439A (en) 1986-03-25 1990-03-06 Pb Diagnostic Systems, Inc. Biological diagnostic device and method of use
US4902424A (en) 1986-10-20 1990-02-20 Memetc North America Corp. Ultrafiltration thin film membranes
US4814082A (en) 1986-10-20 1989-03-21 Memtec North America Corporation Ultrafiltration thin film membranes
US4971904A (en) 1987-06-26 1990-11-20 E. I. Du Pont De Nemours And Company Heterogeneous immunoassay
US4935141A (en) 1987-08-31 1990-06-19 Gambro, Dialysatoren Kg Selectively permeable asymmetric membranes suitable for use in hemodialysis and processes for manufacturing such membranes
US4977078A (en) 1987-12-22 1990-12-11 Olympus Optical Co., Ltd. Plate substrate immunoassay device and method for performing a multi-test immunoassay on a specimen
US4801380A (en) 1987-12-23 1989-01-31 The Texas A&M University System Method of producing a silicon film with micropores
US4916110A (en) 1988-11-01 1990-04-10 W. L. Gore & Associates, Inc. Microporous catalytic material and support structure
US5474675A (en) 1988-11-17 1995-12-12 Herco-Cff Chiralflow Filtertechnik Gmbh Filter separator for separating a composite fluid
US5013337A (en) 1988-12-06 1991-05-07 Uop Process for separating a mixture of molecular species using crystalline microporous metal sulfide compositions
US5204239A (en) * 1990-01-09 1993-04-20 Yeda Research And Development Co., Ltd. Biosensors including lipid bilayer doped with ion channels anchored to a recording electrode by bridging molecules
US6054034A (en) 1990-02-28 2000-04-25 Aclara Biosciences, Inc. Acrylic microchannels and their use in electrophoretic applications
US5858188A (en) 1990-02-28 1999-01-12 Aclara Biosciences, Inc. Acrylic microchannels and their use in electrophoretic applications
US5019263A (en) 1990-06-05 1991-05-28 Mobil Oil Corp. Membrane composed of a pure molecular sieve
US5147606A (en) 1990-08-06 1992-09-15 Miles Inc. Self-metering fluid analysis device
US5622831A (en) 1990-09-26 1997-04-22 Immunivest Corporation Methods and devices for manipulation of magnetically collected material
US5587070A (en) 1990-11-06 1996-12-24 Pall Corporation System for processing biological fluid
US5145584A (en) 1990-12-05 1992-09-08 Allied-Signal Inc. Processes for using a thin film composite ultrafiltration membrane
US5266207A (en) 1991-04-30 1993-11-30 Techsep Composite nanofiltration membrane
US5296375A (en) 1992-05-01 1994-03-22 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices
US5427946A (en) 1992-05-01 1995-06-27 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices
US5866345A (en) 1992-05-01 1999-02-02 The Trustees Of The University Of Pennsylvania Apparatus for the detection of an analyte utilizing mesoscale flow systems
US5928880A (en) * 1992-05-01 1999-07-27 Trustees Of The University Of Pennsylvania Mesoscale sample preparation device and systems for determination and processing of analytes
US5304487A (en) 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
WO1993022053A1 (en) 1992-05-01 1993-11-11 Trustees Of The University Of Pennsylvania Microfabricated detection structures
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US6156270A (en) 1992-05-21 2000-12-05 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6893881B1 (en) 1992-09-14 2005-05-17 Abbott Laboratories, Inc. Method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
WO1994029707A1 (en) 1993-06-08 1994-12-22 British Technology Group Usa Inc. Microlithographic array for macromolecule and cell fractionation
US5837115A (en) 1993-06-08 1998-11-17 British Technology Group Usa Inc. Microlithographic array for macromolecule and cell fractionation
US5427663A (en) 1993-06-08 1995-06-27 British Technology Group Usa Inc. Microlithographic array for macromolecule and cell fractionation
US5843767A (en) 1993-10-28 1998-12-01 Houston Advanced Research Center Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions
US5753014A (en) 1993-11-12 1998-05-19 Van Rijn; Cornelis Johannes Maria Membrane filter and a method of manufacturing the same as well as a membrane
US6044981A (en) 1994-03-07 2000-04-04 The Regents Of The University Of California Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters
US5798042A (en) 1994-03-07 1998-08-25 Regents Of The University Of California Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters
US6265229B1 (en) 1994-03-10 2001-07-24 Oystein Fodstad Method and device for detection of specific target cells in specialized or mixed cell populations and solutions containing mixed cell populations
US5541072A (en) 1994-04-18 1996-07-30 Immunivest Corporation Method for magnetic separation featuring magnetic particles in a multi-phase system
US5716527A (en) 1994-07-08 1998-02-10 Exxon Research & Engineering Company Zeolite membrane with a selectivity enhancing coating
US6090289A (en) 1994-07-08 2000-07-18 Exxon Research & Engineering Co. Molecular sieves and processes for their manufacture
US5871650A (en) 1994-07-08 1999-02-16 Exxon Research And Engineering Company Supported zeolite membranes with controlled crystal width and preferred orientation grown on a growth enhancing layer
US6022590A (en) 1994-07-14 2000-02-08 Competitive Technologies, Inc. Stepwise formation of multilayered nanostructures from macromolecular precursors
US5637458A (en) 1994-07-20 1997-06-10 Sios, Inc. Apparatus and method for the detection and assay of organic molecules
US6033546A (en) 1994-08-01 2000-03-07 Lockheed Martin Energy Research Corporation Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis
US5858195A (en) 1994-08-01 1999-01-12 Lockheed Martin Energy Research Corporation Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis
US5707799A (en) 1994-09-30 1998-01-13 Abbott Laboratories Devices and methods utilizing arrays of structures for analyte capture
US5750339A (en) 1994-11-30 1998-05-12 Thomas Jefferson University Methods for identifying fetal cells
US5935822A (en) * 1995-03-21 1999-08-10 The Regents Of The University Of Colorado Product and process for membrane and soluble polypeptide segregation
US6187446B1 (en) 1995-03-29 2001-02-13 Pharmacia Biotech Ab Carrier matrix for integrated microanalysis systems, method for the production thereof and use of the same
US5674592A (en) 1995-05-04 1997-10-07 Minnesota Mining And Manufacturing Company Functionalized nanostructured films
US5709943A (en) 1995-05-04 1998-01-20 Minnesota Mining And Manufacturing Company Biological adsorption supports
US5639669A (en) 1995-06-07 1997-06-17 Ledley; Robert Separation of fetal cells from maternal blood
US5715946A (en) 1995-06-07 1998-02-10 Reichenbach; Steven H. Method and apparatus for sorting particles suspended in a fluid
US6387290B1 (en) 1995-06-16 2002-05-14 University Of Washington Tangential flow planar microfabricated fluid filter
US20050250199A1 (en) 1995-06-29 2005-11-10 Anderson Rolfe C Integrated nucleic acid diagnostic device
US20010036672A1 (en) 1995-06-29 2001-11-01 Anderson Rolfe C. Integrated nucleic acid diagnostic device
US5876830A (en) 1995-09-08 1999-03-02 Board Of Regents Of The University Of Colorado Method of assembly of molecular-sized nets and scaffolding
US6190638B1 (en) 1996-01-04 2001-02-20 Exxon Chemical Patents Inc. Molecular sieves and process for their manufacture
US6177373B1 (en) 1996-03-14 2001-01-23 Exxon Chemicals Patents Inc Procedure for preparing molecular sieve films
US6100393A (en) 1996-03-15 2000-08-08 Antibioticos, S.A. Process for purifying 7-substituted aminodeacetoxy-cephalosporins through the use of filtration membranes
US5891651A (en) 1996-03-29 1999-04-06 Mayo Foundation For Medical Education And Research Methods of recovering colorectal epithelial cells or fragments thereof from stool
US20020123078A1 (en) 1996-04-25 2002-09-05 Michael Seul Array cytometry
US6958245B2 (en) 1996-04-25 2005-10-25 Bioarray Solutions Ltd. Array cytometry
US6251691B1 (en) 1996-04-25 2001-06-26 Bioarray Solutions, Llc Light-controlled electrokinetic assembly of particles near surfaces
US6309798B1 (en) 1996-05-08 2001-10-30 Studiengesellschaft Kohle Mbh Lithographical process for production of nanostructures on surfaces
US6344326B1 (en) 1996-07-30 2002-02-05 Aclara Bio Sciences, Inc. Microfluidic method for nucleic acid purification and processing
US6074827A (en) 1996-07-30 2000-06-13 Aclara Biosciences, Inc. Microfluidic method for nucleic acid purification and processing
US5770029A (en) 1996-07-30 1998-06-23 Soane Biosciences Integrated electrophoretic microdevices
US6007690A (en) 1996-07-30 1999-12-28 Aclara Biosciences, Inc. Integrated microfluidic devices
US6613525B2 (en) 1996-07-30 2003-09-02 Aclara Biosciences, Inc. Microfluidic apparatus and method for purification and processing
WO1998010267A1 (en) 1996-09-04 1998-03-12 Technical University Of Denmark A micro flow system for particle separation and analysis
US6432630B1 (en) 1996-09-04 2002-08-13 Scandinanian Micro Biodevices A/S Micro-flow system for particle separation and analysis
DE19712309A1 (en) 1996-11-16 1998-05-20 Nmi Univ Tuebingen Microelement arrangement, method for contacting cells in a liquid environment and method for producing a microelement arrangement
US6315940B1 (en) 1996-11-16 2001-11-13 Nmi Naturwissenschaftliches Und Medizinisches Institut An Der Universitat Tubingen In Reutlingen Microelement device
US6503452B1 (en) 1996-11-29 2003-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biosensor arrays and methods
US6043177A (en) 1997-01-21 2000-03-28 University Technology Corporation Modification of zeolite or molecular sieve membranes using atomic layer controlled chemical vapor deposition
US6051517A (en) 1997-01-21 2000-04-18 University Technology Corp. Modified zeolite membrane
US6060415A (en) 1997-02-10 2000-05-09 National Science Council Aligned molecular sieve crystals grown on anodic alumina membrane
US6444461B1 (en) 1997-04-04 2002-09-03 Caliper Technologies Corp. Microfluidic devices and methods for separation
US6264044B1 (en) 1997-04-11 2001-07-24 Cuno, Inc. Reinforced, three zone microporous membrane
US5993661A (en) 1997-04-14 1999-11-30 The Research Foundation Of State University Of New York Macroporous or microporous filtration membrane, method of preparation and use
US5938923A (en) 1997-04-15 1999-08-17 The Regents Of The University Of California Microfabricated filter and capsule using a substrate sandwich
US6632619B1 (en) 1997-05-16 2003-10-14 The Governors Of The University Of Alberta Microfluidic system and methods of use
US6596144B1 (en) 1997-05-27 2003-07-22 Purdue Research Foundation Separation columns and methods for manufacturing the improved separation columns
US6261928B1 (en) 1997-07-22 2001-07-17 Commissariat A L 'energie Atomique Producing microstructures or nanostructures on a support
US6368871B1 (en) 1997-08-13 2002-04-09 Cepheid Non-planar microstructures for manipulation of fluid samples
US6051372A (en) 1997-09-09 2000-04-18 Nimbus Biotechnologie Gmbh Template induced patterning of surfaces and their reversible stabilization using phase transitions of the patterned material
US20020005354A1 (en) 1997-09-23 2002-01-17 California Institute Of Technology Microfabricated cell sorter
US6540895B1 (en) 1997-09-23 2003-04-01 California Institute Of Technology Microfabricated cell sorter for chemical and biological materials
US6241894B1 (en) 1997-10-10 2001-06-05 Systemix High gradient magnetic device and method for cell separation or purification
EP0919812B1 (en) 1997-11-22 2004-10-06 Wardlaw, Stephen Clark Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hemotologic progenitor cells in whole blood
US6197523B1 (en) 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
US20020172987A1 (en) 1998-02-12 2002-11-21 Terstappen Leon W.M.M. Methods and reagents for the rapid and efficient isolation of circulating cancer cells
US6132607A (en) 1998-02-20 2000-10-17 The Florida State University System for continuous magnetic separation of components from a mixture
WO1999044064A1 (en) 1998-02-27 1999-09-02 Cli Oncology, Inc. Method and compositions for differential detection of primary tumor cells and metastatic cells
US6641997B1 (en) * 1998-03-20 2003-11-04 The Rockefeller University Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
US6383759B1 (en) 1998-05-04 2002-05-07 Gerald P. Murphy Cancer Foundation Non-invasive method to detect prostate cancer
US6200765B1 (en) 1998-05-04 2001-03-13 Pacific Northwest Cancer Foundation Non-invasive methods to detect prostate cancer
US6465225B1 (en) 1998-06-29 2002-10-15 Evotec Oai Ag Method and device for manipulating particles in microsystems
US6596545B1 (en) * 1998-07-14 2003-07-22 Zyomyx, Inc. Microdevices for screening biomolecules
US6582969B1 (en) 1998-07-14 2003-06-24 Zyomyx, Inc. Microdevices for high-throughput screening of biomolecules
US6576478B1 (en) 1998-07-14 2003-06-10 Zyomyx, Inc. Microdevices for high-throughput screening of biomolecules
US6329209B1 (en) * 1998-07-14 2001-12-11 Zyomyx, Incorporated Arrays of protein-capture agents and methods of use thereof
US6454938B2 (en) 1998-09-17 2002-09-24 Kionix, Inc. Integrated monolithic microfabricated electrospray and liquid chromatography system and method
US6450047B2 (en) * 1998-11-09 2002-09-17 Agilent Technologies, Inc. Device for high throughput sample processing, analysis and collection, and methods of use thereof
US6113795A (en) 1998-11-17 2000-09-05 The University Of Kansas Process and apparatus for size selective separation of micro- and nano-particles
US6277489B1 (en) 1998-12-04 2001-08-21 The Regents Of The University Of California Support for high performance affinity chromatography and other uses
US6113794A (en) 1999-01-25 2000-09-05 Kumar; Ashwani Composite solvent resistant nanofiltration membranes
US6960449B2 (en) 1999-02-10 2005-11-01 Cell Works Diagnostics, Inc. Class characterization of circulating cancer cells isolated from body fluids and methods of use
WO2000062931A1 (en) 1999-04-21 2000-10-26 Clinical Micro Sensors, Inc. The use of microfluidic systems in the electrochemical detection of target analytes
US6635163B1 (en) 1999-06-01 2003-10-21 Cornell Research Foundation, Inc. Entropic trapping and sieving of molecules
US6664104B2 (en) 1999-06-25 2003-12-16 Cepheid Device incorporating a microfluidic chip for separating analyte from a sample
US6911345B2 (en) 1999-06-28 2005-06-28 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US6762059B2 (en) 1999-08-13 2004-07-13 U.S. Genomics, Inc. Methods and apparatuses for characterization of single polymers
US6361958B1 (en) 1999-11-12 2002-03-26 Motorola, Inc. Biochannel assay for hybridization with biomaterial
US6570196B1 (en) * 2000-03-22 2003-05-27 Max-Plank-Gesellschaft Zur Forderung Der Wissenschaften Lipid vesicles or lipid bilayers on chips
WO2002012896A1 (en) 2000-08-08 2002-02-14 Aviva Biosciences Corporation Methods for manipulating moieties in microfluidic systems
US6818184B2 (en) 2000-08-31 2004-11-16 The Regents Of The University Of California Capillary array and related methods
US20020058332A1 (en) 2000-09-15 2002-05-16 California Institute Of Technology Microfabricated crossflow devices and methods
WO2002028523A2 (en) 2000-09-30 2002-04-11 Aviva Biosciences Corporation Apparatuses containing multiple force generating elements and uses thereof
WO2002030562A1 (en) 2000-10-10 2002-04-18 Aviva Biosciences Corporation An integrated biochip system for sample preparation and analysis
US20020132316A1 (en) 2000-11-13 2002-09-19 Genoptix Methods and apparatus for sorting of bioparticles based upon optical spectral signature
US20020108859A1 (en) 2000-11-13 2002-08-15 Genoptix Methods for modifying interaction between dielectric particles and surfaces
US20020115164A1 (en) 2000-11-13 2002-08-22 Genoptix Methods and apparatus for generating and utilizing a moving optical gradient
US20020115163A1 (en) 2000-11-13 2002-08-22 Genoptix Methods for sorting particles by size and elasticity
US20020123112A1 (en) 2000-11-13 2002-09-05 Genoptix Methods for increasing detection sensitivity in optical dielectric sorting systems
US20020132315A1 (en) 2000-11-13 2002-09-19 Genoptix Methods and apparatus for measurement of dielectric constants of particles
US20050164158A1 (en) 2000-11-28 2005-07-28 The Regents Of The University Of California, A California Corporation Microfluidic sorting device
US20020090741A1 (en) 2001-01-08 2002-07-11 Jurgensen Stewart Russell Method of separating cells from a sample
EP1221342A2 (en) 2001-01-08 2002-07-10 Becton, Dickinson and Company Method for seperating cells from a sample
US6685841B2 (en) 2001-02-14 2004-02-03 Gabriel P. Lopez Nanostructured devices for separation and analysis
US6913697B2 (en) 2001-02-14 2005-07-05 Science & Technology Corporation @ Unm Nanostructured separation and analysis devices for biological membranes
US6815664B2 (en) 2001-04-27 2004-11-09 Genoptix, Inc. Method for separation of particles
US20060060767A1 (en) 2001-04-27 2006-03-23 Wang Mark M Methods and apparatus for use of optical forces for identification, characterization and/or sorting of particles
US20050049793A1 (en) 2001-04-30 2005-03-03 Patrizia Paterlini-Brechot Prenatal diagnosis method on isolated foetal cell of maternal blood
US20050175996A1 (en) 2001-05-09 2005-08-11 Xiangning Chen Multiple sequencible and ligatible structures for genomic analysis
WO2003000418A2 (en) 2001-06-20 2003-01-03 Cytonome, Inc. Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system
US6881315B2 (en) 2001-08-03 2005-04-19 Nec Corporation Fractionating apparatus having colonies of pillars arranged in migration passage at interval and process for fabricating pillars
US20030077292A1 (en) 2001-09-19 2003-04-24 The Regents Of The University Of Michigan Detection and treatment of cancers of the lung
US20030072682A1 (en) 2001-10-11 2003-04-17 Dan Kikinis Method and apparatus for performing biochemical testing in a microenvironment
WO2003031938A2 (en) 2001-10-11 2003-04-17 Aviva Biosciences Corporation Methods, compositions, and automated systems for separating rare cells from fluid samples
US20060252054A1 (en) 2001-10-11 2006-11-09 Ping Lin Methods and compositions for detecting non-hematopoietic cells from a blood sample
US6783647B2 (en) 2001-10-19 2004-08-31 Ut-Battelle, Llc Microfluidic systems and methods of transport and lysis of cells and analysis of cell lysate
WO2003035894A2 (en) 2001-10-26 2003-05-01 Immunivest Corporation Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
US20050244843A1 (en) 2001-11-16 2005-11-03 Wen-Tien Chen Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
EP1462800A1 (en) 2001-12-11 2004-09-29 Netech Inc. Blood cell separation system
US20030159999A1 (en) 2002-02-04 2003-08-28 John Oakey Laminar Flow-Based Separations of Colloidal and Cellular Particles
EP1338894A2 (en) 2002-02-26 2003-08-27 Agilent Technologies, Inc. Mobile phase gradient generation microfluidic device
WO2003079006A1 (en) 2002-03-20 2003-09-25 Monica Almqvist Microfluidic cell and method for sample handling
WO2003085379A2 (en) 2002-04-01 2003-10-16 Fluidigm Corporation Microfluidic particle-analysis systems
US20040072278A1 (en) 2002-04-01 2004-04-15 Fluidigm Corporation Microfluidic particle-analysis systems
WO2004004906A1 (en) 2002-07-03 2004-01-15 Nanostream, Inc. Microfluidic closed-end metering systems and methods
US20040018116A1 (en) 2002-07-26 2004-01-29 Desmond Sean M. Microfluidic size-exclusion devices, systems, and methods
WO2004015411A1 (en) 2002-08-08 2004-02-19 Nanostream, Inc. Systems and methods for high-throughput microfluidic sample analysis
US20050092662A1 (en) 2002-09-09 2005-05-05 Cytonome, Inc. Implementation of microfluidic components in a microfluidic system
US6878271B2 (en) 2002-09-09 2005-04-12 Cytonome, Inc. Implementation of microfluidic components in a microfluidic system
US20050145497A1 (en) 2002-09-09 2005-07-07 Cytonome, Inc. Implementation of microfluidic components in a microfluidic system
US20040245102A1 (en) 2002-09-09 2004-12-09 Gilbert John R. Implementation of microfluidic components, including molecular fractionation devices, in a microfluidic system
WO2004024327A1 (en) 2002-09-12 2004-03-25 Intel Corporation Microfluidic apparatus with integrated porous-substrates/sensor for real-time(bio)chemical molecule detection
US20060134599A1 (en) 2002-09-27 2006-06-22 Mehmet Toner Microfluidic device for cell separation and uses thereof
WO2004029221A2 (en) 2002-09-27 2004-04-08 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US20050262577A1 (en) 2002-09-27 2005-11-24 Christian Guelly Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
US7150812B2 (en) 2002-10-23 2006-12-19 The Trustees Of Princeton University Method for continuous particle separation using obstacle arrays asymmetrically aligned to fields
US20040144651A1 (en) 2002-10-23 2004-07-29 Huang Lotien Richard Method for continuous particle separation using obstacle arrays asymmetrically aligned to fields
WO2004037374A2 (en) 2002-10-23 2004-05-06 The Trustees Of Princeton University Method for continuous particle separation using obstacle arrays asymmetrically aligned to fields
EP1418003A1 (en) 2002-10-31 2004-05-12 Hewlett-Packard Development Company, L.P. Microfluidic pumping system
WO2004056978A1 (en) 2002-12-19 2004-07-08 Ivonex Gmbh Method for the separation of cell fractions
US20040121343A1 (en) 2002-12-24 2004-06-24 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US6746503B1 (en) 2003-01-30 2004-06-08 The Regents Of The University Of California Precision gap particle separator
US20040232074A1 (en) 2003-03-21 2004-11-25 Ralf-Peter Peters Microstructured separating device and microfluidic process for separating liquid components from a particle-containing liquid
US20050236314A1 (en) 2003-05-20 2005-10-27 Neyer David W Variable flow rate injector
WO2004113877A1 (en) 2003-06-13 2004-12-29 The General Hospital Corporation Microfluidic systems for size based removal of red blood cells and platelets from blood
US20050170373A1 (en) 2003-09-10 2005-08-04 Althea Technologies, Inc. Expression profiling using microarrays
US20050239101A1 (en) 2003-10-28 2005-10-27 The Johns Hopkins University School Of Medicine Quantitative multiplex methylation-specific PCR
WO2005043121A2 (en) 2003-10-31 2005-05-12 Vitatex, Inc. Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
WO2005047529A1 (en) 2003-11-04 2005-05-26 Aviva Biosciences Corporation Methods, compositions, and automated systems for separating rare cells from fluid samples
WO2005049168A2 (en) 2003-11-17 2005-06-02 Immunivest Corporation Method and apparatus for pre-enrichment and recovery of cells from densified whole blood
US20050123454A1 (en) 2003-12-08 2005-06-09 David Cox Microfluidic device and material manipulating method using same
WO2005058937A2 (en) 2003-12-12 2005-06-30 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
US20050142663A1 (en) 2003-12-24 2005-06-30 3M Innovative Properties Company Methods for nucleic acid isolation and kits using a microfluidic device and concentration step
WO2005068503A2 (en) 2004-01-07 2005-07-28 Chiron Corporation M-csf-specific monoclonal antibody and uses thereof
US20050191636A1 (en) 2004-03-01 2005-09-01 Biocept, Inc. Detection of STRP, such as fragile X syndrome
US20050266433A1 (en) 2004-03-03 2005-12-01 Ravi Kapur Magnetic device for isolation of cells and biomolecules in a microfluidic environment
WO2005084374A2 (en) 2004-03-03 2005-09-15 The General Hospital Corporation Magnetic device for isolation of cells and biomolecules in a microfluidic environment
WO2005085861A2 (en) 2004-03-03 2005-09-15 Oridis Biomed Forschungs- Und Entwicklungs Gmbh Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer
US20050211556A1 (en) 2004-03-25 2005-09-29 Childers Winthrop D Method of sorting cells on a biodevice
WO2005108621A1 (en) 2004-04-30 2005-11-17 Yale University Methods and compositions for cancer diagnosis
US20050282196A1 (en) 2004-04-30 2005-12-22 Jose Costa Methods and compositions for cancer diagnosis
WO2005109238A2 (en) 2004-05-03 2005-11-17 Cygene Laboratories, Inc. Method and system for a comprehensive knowledge-based anonymous testing and reporting, and providing selective access to test results and report
US20050250111A1 (en) 2004-05-05 2005-11-10 Biocept, Inc. Detection of chromosomal disorders
US20050252840A1 (en) 2004-05-13 2005-11-17 Eksigent Technologies, Llc Micromixer
WO2005121362A2 (en) 2004-06-14 2005-12-22 Inserm (Institut National De La Sante Et De La Recherche Medicale Method for selectively quantifying vegf isoforms in a biological sample and uses thereof.
US20060051265A1 (en) 2004-09-08 2006-03-09 Health Research, Inc. Apparatus and method for sorting microstructures in a fluid medium
US20060160243A1 (en) 2005-01-18 2006-07-20 Biocept, Inc. Recovery of rare cells using a microchannel apparatus with patterned posts
WO2006078470A2 (en) 2005-01-18 2006-07-27 Biocept, Inc. Cell separation using microchannel having patterned posts
US20060252087A1 (en) 2005-01-18 2006-11-09 Biocept, Inc. Recovery of rare cells using a microchannel apparatus with patterned posts
US20050170418A1 (en) 2005-02-18 2005-08-04 John Moreland Microfluidic platform of arrayed switchable spin-valve elements for high-throughput sorting and manipulation of magnetic particles and biomolecules
US20070026381A1 (en) 2005-04-05 2007-02-01 Huang Lotien R Devices and methods for enrichment and alteration of cells and other particles
US20060223178A1 (en) 2005-04-05 2006-10-05 Tom Barber Devices and methods for magnetic enrichment of cells and other particles
US20070099207A1 (en) 2005-04-05 2007-05-03 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026417A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026413A1 (en) 2005-07-29 2007-02-01 Mehmet Toner Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026469A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026418A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026419A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026416A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026414A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026415A1 (en) 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070059683A1 (en) 2005-09-15 2007-03-15 Tom Barber Veterinary diagnostic system
US20070059680A1 (en) 2005-09-15 2007-03-15 Ravi Kapur System for cell enrichment
US20070059718A1 (en) 2005-09-15 2007-03-15 Mehmet Toner Systems and methods for enrichment of analytes
US20070059781A1 (en) 2005-09-15 2007-03-15 Ravi Kapur System for size based separation and analysis
US20070059774A1 (en) 2005-09-15 2007-03-15 Michael Grisham Kits for Prenatal Testing
US20070059719A1 (en) 2005-09-15 2007-03-15 Michael Grisham Business methods for prenatal Diagnosis
US20070059716A1 (en) 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality

Non-Patent Citations (78)

* Cited by examiner, † Cited by third party
Title
"Micromechanics Imitate Blood Vessels" Design News 15 (Mar. 22, 1993).
Archer, et al. Cell Reactions to Dielectrophoretic Manipulation. Biochemical and Biophysical Research Communications. 1999;257:687-98.
Ashcroft, et al. Solid State Physics. Saunders College Publishing. Orlando, FL. 1976 (Table of Contents only).
Babochkina, T. I. Ph. D. Dissertation-Fetal cells in maternal circulation: Fetal cell Separation and FISH analysis. University of Basel, Switzerland. Dec. 8, 2005. (123 pages).
Bauer, J. Advances in cell separation: recent developments in counterflow centrifugal elutriation and continuous flow cell separation. Journal of Chromatography. 1999;722:55-69.
Becker, et al. Fabrication of Microstructures With High Aspect Ratios and Great Structural Heights by Synchrotron Radiation Lithography, Galvanoforming, and Plastic Moulding (LIGA Process). Microelectronic Engineering. 1986;4:35-56.
Becker, et al. Planar quartz chips with submicron channels for two-dimensional capillary electrophoresis applications. J. Micromech Microeng.1998;9:24-28.
Beebe et al. Functional Hydrogel Structures for Autonomous Flow Control Inside Microfluidic Channels. Nature. 2000; 404:558-590.
Benincasa, et al. Cell Sorting by One Gravity SPLITT Fractionation. Analytical Chemistry. 2005; 77(16):5294-5301.
Berg. H. C. Random Walks in Biology, Ch. 4. Princeton University Press. Princeton, NJ. 1993. pp. 48-64.
Cao, et al. Fabrication of 10 nm enclosed nanofluidic channels. Applied Physics Letters. 2002; 81(1): 174-6.
Cao, et al. Gradient nanostructures for interfacing microfluidics and nanofluidics. Applied Physics Letters. 2002; 81(16): 3058-60.
Carlson, et al. Self-Sorting of White Blood Cells in a Lattice. Phys. Rev. Lett. 79:2149-2152 (1997).
Chiou, et al. Sorting by diffusion: An asymmetric obstacle course for continuous molecular separation. PNAS. 1999; 96(24):13762-13765.
Chiu, et al. Patterned Deposition of Cells and Proteins Onto Surfaces by Using Three-Dimensional Microfluidic Systems. Proceedings of the National Academy of Sciences of the United States of America. 2000; pp. 2408-2413.
Chou, et al. A Microfabricated Device for Sizing and Sorting DNA Molecules. Proceedings of the National Academy of Sciences of the United States of America. 1999; pp. 11-13.
Chou, et al. Imprint of sub-25 nm vias and trenches in polymers. Applied Physics Letters. 1995; 67(21): 3114-6.
Colburn, et al. Patterning nonflat substrates with a low pressure, room temperature, imprint lithography process. Journal of Vacuum Science & Technology B (Microelectronics and Nanometer Structures). 2001; 19(6): 2162-72.
Craighead, et al. Nanoelectromechanical systems. Science. 2000; 290(5496): 1532-5.
Das, et al. Dielectrophoretic segregation of different human cell types on microscope slides. Anal. Chem. 2005; 77:2708-2719.
De Kretser, et al. The Separation of Cell Populations using Monoclonal Antibodies attached to Sepharose. Tissue Antigens. 1980;16:317-325.
Delamarche, et al. Microfluidic Networks for Chemical Patterning of Substrates: Design and Application to Bioassays. Journal of the American Chemical Society. 1998; 120:500-508.
Delamarche, et al. Patterned Delivery of Immunoglobulins to Surfaces Using Microfluidic Networks. Science. 1997; 276:779-781.
Deshmukh, et al. Continuous Micromixer With Pulsatile Micropumps. Solid-State Sensor and Actuator Workshop. Hilton Head Island, South Carolina; Jun. 4-8, 2000:73-76.
Doyle, et al. Self-Assembled Magnetic Matrices for DNA Separation Chips. Science 295:2237 (2002).
Eigen, et al. Sorting Single Molecules: Application to Diagnostics and Evolutionary Biotechnology. Proceedings of the National Academy of Sciences of the United States of America. 1994; 91:5740-5747.
Evans, et al. The Bubble Spring and Channel (BSAC) Valve: An Actuated, Bi-Stable Mechanical Valve For In-Plane Fluid Control. Transducers '99. Sendai, Japan; Jun. 7-10, 1999.
Fan, et al. Molecular dynamics simulation of a liquid in a complex nano channel flow. Physics of Fluids. 2002; 14(3):1146-53.
Farooqui, et al. Microfabrication of Submicron Nozzles in Silicon Nitride. Journal of Microelectromechanical Systems. 1992; 1(2):86-88.
Fiedler, et al. Dielectrophoretic Sorting of Particles and Cells in a Microsystem. Analytical Chemistry. 1998; pp. 1909-1915.
Freemantle, M. Downsizing Chemistry. Chemical analysis and synthesis on microchips promise a variety of potential benefits. Chemical & Engineering News. 1999; pp. 27-36.
Fu, et al. A Microfabricated Fluorescence-Activated Cell Sorter. Nature Biotechnology.1999; 17:1109-1111.
Fu, et al. An integrated miscrofabricated cell sorter. Anal Chem. 2002;74:2451-2457.
Fuhr, et al. Biological Application of Microstructures. Topics in Current Chemistry. 1997; 194:83-116.
Giddings, J. C. Chemistry 'Eddy' Diffusion in Chromatography. Nature. 1959;184:357-358.
Giddings, J. C. Field-Flow Fractionation: Analysis of Macromolecular, Colloidal, and Particulate Materials. Science. 1993;260:1456-1465.
Giddings, J.C. Unified Separation Science. John Wiley & Sons, Inc. 1991; cover page & Table of Contents only.
Han, et al. Separation of Long DNA Molecules in a Microfabricated Entropic Trap Array. Science. 2000;288:1026-1029.
Harnett, et al. Heat-depolymerizable polycarbonates as electron beam patternable sacrifical layers for nanofluidics. Journal of Vacuum Science & Technology B (Microelectronics and Nanometer Structures). 2001; 19(6): 2842-5.
Hibara, et al. Nanochannels on a fused-silica microchip and liquid properties investigation by time-resolved fluorescence measurements. Analytical Chemistry. 2002; 74(24): 6170-6.
Huang, et al. A DNA prism for high-speed continuous fractionation of large DNA molecules. Nature Biotechnology. 2002;20:1048-1051.
Huang, et al. Continuous Particle Separation Through Deterministic Lateral Displacement. Science 304:987-90 (2004).
Huang, et al. Electric Manipulation of Bioparticles and Macromoledules on Microfabricated Electrodes. Analytical Chemistry. 2001; pp. 1549-1559.
Huang, et al. Role of Molecular Size in Ratchet Fractionation. 2002; 89(17):178301-1-178301-4.
Huh, et al. Gravity-driven microhydrodynamics-based cell sorter (microHYCS) for rapid, inexpensive, and efficient cell separation and size-profiling. 2nd Annual International IEEE-EMBS Special Topic Conference on Microtechnology in Medicine and Biology. Madison, Wisconsin USA; MAY 2-4, 2002:466-469.
Ivker, M. Direct Observation of Reptation in Artificial Gel Environments. Bachelor of Arts thesis, Princeton University. Spring 1991.
Jeon, et al. Generation of Solution and surface Gradients Using Microfluidic Systems. Langmuir. 2000, pp. 8311-8316.
Kamholz, et al. Quantitative Analysis of Molecular Interaction in a Microfluidic Channel: the T-Sensor. Analytical Chemistry. 1999; pp. 5340-5347.
Kapur, et al., U.S. Appl. No. 11/227,904, entitled "Devices And Methods For Enrichment And Alteration Of Cells And Other Particles," filed Sep. 15, 2005.
Kenis, et al. Microfabrication Inside Capillaries Using Multiphase Laminar Flow Patterning. Science. 1999; 285:83-85.
Kim, et al. Polymer microstructures formed by moulding in capillaries. Nature. 1995;376:581-584.
Kumar, et al. Cell Separation: A Review. Pathology. 1984;16:53-62.
Li, et al. Transport, Manipulation, and Reaction of Biological Cells On-Chip Using Electrokinetic Effects. Analytical Chemistry., 1997; pp. 1564-1568.
Mehrishi, et al. Electrophoresis of cells and the biological relevance of surface charge. Electrophoresis. 2002;23:1984-1994.
Mohamed, et al. Development of a rare cell fractionation device: application for cancer detection. IEEE Trans Nanobioscience. 2004; 3(4): 251-6.
Moore, et al. Lymphocyte fractionation using immunomagnetic colloid and a dipole magnet flow cell sorter. J Biochem Biophys Methods. 1998;37:11-33.
Oakey et al. Laminar Flow-Based Separations at the Microscale. Biotechnology Progress. 2002; pp. 1439-1442.
Olson, et al. An In Situ Flow Cytometer for the Optical Analysis of Individual Particles in Seawater. Available at http://www.whoi.edu/science/B/Olsonlab/insitu2001.htm. Accessed Apr. 24, 2006.
Petersen, et al. The Promise of Miniaturized Clinical Diagnostic Systems. IVD Technol. 4:43-49 (1998).
Product literature for GEM, a system for blood testing: GEM Premier 3000. Avaiable at http://www.ilus.com/premier_gem 3000_iqm.asp. Accessed Apr. 24, 2006.
Raymond, et al. Continuous Separation of High Molecular Weight Compounds Using a Microliter Volume Free-Flow Electrophoresis Microstructure. 1996;68:2515-2522.
Rice, et al. Electrokinetic flow in a cylindrical capillary. Journal of Physical Chemistry. 1965; 69(11): 4017-24.
Sethu, et al. Continuous Flow Microfluidic Device for Rapid Erythrocyte Lysis. Anal. Chem. 76:6247-6253 (2004).
Studer, et al. Nanoembossing of thermoplastic polymers for microfluidic applications. Applied Physics Letters. 2002; 80(19): 3614-6.
Takayama, et al. Patterning Cells and Their Environments Using Multiple Laminar Fluid Flows in Capillary Networks. Proceedings of the National Academy of Sciences of the United States of America. 1999:5545-5548.
Takayama, et al. Subcellular Position of Small Molecues. Nature. 2001; 411:1016.
Toner, et al. Blood-on-a-Chip. Annu. Rev. Biomed. Eng. 7:77-103, C1-C3 (2005).
Tong, et al. Low Temperature Wafer Direct Bonding. Journal of Microelectromechanical Systems. 1994;3:29-35.
Turner, et al. Confinement-Induced Entropic Recoil of Single DNA Molecules in a Nanofluidic Structure. Physical Review Letters.2002;88:128103.1-128103.4.
Voldman, et al. Holding Forces of Single-Particle Dielectrophoretic Traps. Biophysical Journal.2001:80:531-541.
Volkmuth, et al. DNA electrophoresis in microlithographic arrays. Nature. 1992; 358:600-602.
Volkmuth, et al. Observation of Electrophoresis of Single DNA Molecules in Nanofabricated Arrays. Presentation at joint annual meeting of Biophysical Society and the American Society for Biochemistry and Molecular Biology. Feb. 9-13, 1992.
Weigl, et al. Microfluidic Diffusion-Based Separation and Detection. Science. 1999; pp. 346-347.
Xu, et al. Dielectrophoresis of human red cells in microchips. Electrophoresis.1999;20:1829-1831.
Zaidi, et al. Optical properties of nanoscale, one-dimensional silicon grating structures. Journal of Applied Physics. 1996; 80(12): 6997-7008.
Zankovych, et al. Nanoimprint lithography: challenges and prospects. Nanotechnology. 2001; 12(2): 91-5.
Zhang, et al. High-speed free-flow electrophoresis on chip. Anal Chem. 2003;75:5759-5766.
Zuska, P. Microtechnology Opens Doors to the Universe of Small Space, MD&DI Jan. 1997, p. 131.

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8372579B2 (en) 2002-09-27 2013-02-12 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US20070264675A1 (en) * 2002-09-27 2007-11-15 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US11052392B2 (en) 2002-09-27 2021-07-06 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US10081014B2 (en) 2002-09-27 2018-09-25 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US20090109422A1 (en) * 2006-05-12 2009-04-30 Canon Kabushiki Kaisha Detecting element, detecting device and detecting method
US8045141B2 (en) * 2006-05-12 2011-10-25 Canon Kabushiki Kaisha Detecting element, detecting device and detecting method
US9656261B2 (en) 2009-06-04 2017-05-23 Leidos Innovations Technology, Inc. DNA analyzer
US9067207B2 (en) 2009-06-04 2015-06-30 University Of Virginia Patent Foundation Optical approach for microfluidic DNA electrophoresis detection
US9649631B2 (en) 2009-06-04 2017-05-16 Leidos Innovations Technology, Inc. Multiple-sample microfluidic chip for DNA analysis
US8961764B2 (en) 2010-10-15 2015-02-24 Lockheed Martin Corporation Micro fluidic optic design
US9541480B2 (en) 2011-06-29 2017-01-10 Academia Sinica Capture, purification, and release of biological substances using a surface coating
US11674958B2 (en) 2011-06-29 2023-06-13 Academia Sinica Capture, purification, and release of biological substances using a surface coating
US9988676B2 (en) 2012-02-22 2018-06-05 Leidos Innovations Technology, Inc. Microfluidic cartridge
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
US10495644B2 (en) 2014-04-01 2019-12-03 Academia Sinica Methods and systems for cancer diagnosis and prognosis
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
US10605708B2 (en) 2016-03-16 2020-03-31 Cellmax, Ltd Collection of suspended cells using a transferable membrane

Also Published As

Publication number Publication date
USRE42249E1 (en) 2011-03-29
US20030102263A1 (en) 2003-06-05
USRE42315E1 (en) 2011-05-03
US6913697B2 (en) 2005-07-05

Similar Documents

Publication Publication Date Title
USRE41762E1 (en) Nanostructured separation and analysis devices for biological membranes
US6685841B2 (en) Nanostructured devices for separation and analysis
US20060065528A1 (en) Nanostructured devices for separation and analysis
Tegenfeldt et al. Micro-and nanofluidics for DNA analysis
JP2601595B2 (en) Method and apparatus for moving molecules by applying multiple electric fields
US8512588B2 (en) Method of fabricating a scalable nanoporous membrane filter
US8783466B2 (en) Continuous biomolecule separation in a nanofilter
US20050023156A1 (en) Nanostructured material transport devices and their fabrication by application of molecular coatings to nanoscale channels
US8088282B2 (en) Sieving media from planar arrays of nanoscale grooves, method of making and method of using the same
FR2825649A1 (en) Micro-apparatus, for chemical or biological analysis, comprises fractionation micro-columns with micro-lever assemblies for detection and analysis
Janshoff et al. Micropatterned solid-supported membranes formed by micromolding in capillaries
Holden et al. Microfluidic tools for studying the specific binding, adsorption, and displacement of proteins at interfaces
Rahong et al. Self-assembled nanowire arrays as three-dimensional nanopores for filtration of DNA molecules
Kim et al. In situ curing of sliding SU-8 droplet over a microcontact printed pattern for tunable fabrication of a polydimethylsiloxane nanoslit
Han et al. Lipid bilayer membrane arrays: fabrication and applications
Abdallah Microfluidic Tools for Protein Crystallography
Kazoe et al. Nanofluidic Technologies for Drug Screening and Drug Delivery
Zeng Self-assembled nanostructures for biomolecular analysis
Zeng Self-assembled nanostructures for biomolecular analysis.
Gaudioso et al. Lipid Membranes: Nanostructure and Dynamic Organization
Cross et al. FOR BIOLOGICAL SEPARATIONS
Taylor Biomimetic membrane-assisted architectures for protein sensing using 1-and 2-dimensional surface plasmon resonance spectroscopy
Yamamoto Single molecular level analysis and processing in nanochannels
Piyasena Biosensor and microfluidic technologies based on bead packed microcolumns
Tinazli Nanobiotechnology: tools for proteomics: molecular organization and manipulation of proteins and protein complexes in nanodimensions

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 8